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1 Abstract 
Here we employ a combination of synthetic biology in Schneider cells and verification of 
these results with pharmacological inhibitors in primary human immune cells to investigate 
immune cell regulation. Taking advantage of the high transient co-transfection rate in 
Schneider cells, we were able to create a minimal signaling pathway containing an ITAM-
motif, SYK kinase and its target SLP-76. The co-expression of all ITAM-containing adapters 
investigated resulted in strong activation of SYK kinase as observed by SLP-76 
phosphorylation. Mutation experiments showed that this was dependent on both functional 
tyrosines within the ITAM motif as well as the SH2 domains of SYK kinase. Additionally, we 
observed a requirement for co-expression of Src kinases for ZAP70 mediated phosphorylation 
of SLP-76, whereas SYK was activated just by the presence of ITAMs without the need for 
Src kinases. Inhibitor experiments further underlined this requirement. Src-dependent 
SYK/ZAP70 activation and subsequent phosphorylation of SLP-76 could be controlled by co-
expression of Csk or CD45, providing a molecular basis for this pathway in vivo. 
In primary NK cells, we could demonstrate that SLP-76 is phosphorylated after cross-linking 
of ITAM-associated receptors as predicted by the synthetic approach. NK cells express both 
SYK kinases SYK and ZAP70, whereas B cells only express SYK and T cells only express 
ZAP70. To further investigate the differences in the activation of SYK kinases, we stimulated 
all 3 cell types in the presence of Src or SYK kinase inhibitors. We could show that ZAP70 
activation in T cells could be effectively inhibited by Src kinase inhibitors while NK cells and 
B cells were only partially inhibited at the same concentration thus validating our 
reconstructed pathway in Schneider cells. 
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1.1 Zusammenfassung	(abstract	in	german)	
Zur Untersuchung der Regulation von NK-Zellen wurden in der vorliegenden Arbeit 
Signalkaskaden in Schneiderzellen nachgebaut. Dafür wurden bekannte Komponenten von 
Signalkaskaden aus NK-Zellen transient in Schneiderzellen co-transfiziert und die 
Phosphorylierung von kritischen Signalmolekülen untersucht. Mit Hilfe dieses Ansatzes 
konnten wir in Schneiderzellen eine Signalkaskade mit 3 essentiellen Komponenten 
nachbilden. Ein Adaptermolekül das ein ITAM-Motiv enthält war ausreichend SYK zu 
aktivieren und somit SLP-76 zu phosphorylieren. Durch Mutationsexperimente konnten wir 
zeigen, dass diese Aktivierung abhängig von Tyrosinen im ITAM-Motiv und den SH-2 
Domänen von SYK ist. Die SYK-Kinase ZAP70 hingegen benötigte die Co-Expression einer 
Src-Kinase um aktiviert zu werden. Mit Hilfe von Inhibitorexperimenten konnte diese 
Abhängigkeit weiter demonstriert werden. Die Aktivierung von Src-Kinasen konnte in diesem 
Zusammenhang durch Co-Expression von Csk und CD45 reziprok reguliert werden.  
In primären NK Zellen konnten wie zeigen, dass SLP-76 nach Kreuzvernetzung von ITAM-
assoziierten Rezeptoren - wie von unserem synthetischen Ansatz vorhergesagt – 
phosphoryliert wird. NK Zellen exprimieren die SYK Kinasen SYK und ZAP70, B Zellen nur 
SYK und T Zellen nur ZAP70. Um die Unterschiede der Aktivierung durch Src-Kinasen 
weiter zu untersuchen wurden alle 3 Zelltypen in Anwesenheit von Src oder SYK Inhibitoren 
stimuliert. So konnten wir zeigen, dass die Aktivierung von ZAP70 durch Inhibition von Src-
Kinasen in T Zellen unterdrückt wird, während NK und B Zellen nur teilweise inhibiert 
werden.  
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2 Introduction 
2.1 NK cells 
In the mid-1970s, a novel immune cell type was described based on its ability to lyse 
allogeneic tumor cells without the need for prior sensitization. The term “natural cytotoxicity” 
was introduced to describe this feature and the cells mediating this effect were named natural 
killer (NK) cells [1-5]. In the last 40 years, much progress has been made in the understanding 
of the function and regulation of NK cells. We now know that NK cells contribute to effective 
innate immune responses and provide the first important line of defense against parasites, 
viruses and cancer [6-9]. NK cells derive from the common lymphocyte progenitor, but they 
are independent of a functional thymus and - unlike the antigen receptors of B and T cells - 
rely on germ-line-encoded surface receptors that do not undergo somatic recombination. 
While NK cells can be found among blood lymphocytes, NK cells reside in organs [10] and 
can play a role in organ homeostasis as well [11].  
The immune system is classically grouped into innate and adaptive immune system. The first 
and rapid response upon infection is delivered by the innate immune system composed of 
macrophages, dendritic cells, mast cells, basophils, eosinophils, neutrophils and NK cells. T 
and B cells mediate the adaptive immune response, which is characterized by slow initiation 
and the generation of memory. Adaptive immune cells rely on the expression of 
recombination activation genes – which NK cells do not express – to generate an infinite 
number of B and T cell receptors enabling specificity in the adaptive response after clonal 
expansion. In contrast, NK cells mediate their effector functions rapidly without the 
requirement for further development. However, recent reports indicate memory-like features 
of NK cells which will be discussed later.  
Human NK cells are typically identified as lymphocytes that express CD56 and lack 
expression of CD3. Expression of NKp46 is also mostly restricted to NK cells and therefore 
frequently used as a marker as well. In human blood, NK cells represent 5-15% of the total 
peripheral blood lymphocytes (PBL) and are grouped into CD56dim and CD56bright cells with 
CD56dim NK cells accounting for up to 90% of all NK cells in peripheral blood and spleen 
[12, 13]. In contrast, equal numbers of CD56dim and CD56bright NK cells are found in the liver 
and CD56bright  NK cells are abundant in other organs as well [11].  
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2.1.1 NK cell effector functions as part of the immune response 
High cytotoxic NK cell activity was shown to be associated with a 40% lower cancer risk 
compared to NK cells from people with low cytotoxic NK cell activity [14]. Human NK cell 
deficiency is rare and immune-functions are severely compromised in the absence of NK 
cells. Reports have shown increased susceptibility to Herpesvirus and Papillomavirus 
infections [15]. Because of their ability to eliminate transformed cells, NK cells are 
increasingly used for immunotherapy where NK cells are expanded and activated ex vivo [16-
18]. Recent studies have also focused on the expression of chimeric antigen receptors (CAR) 
in NK and T cells to improve immunotherapy [19, 20]. Despite their limited ability to 
infiltrate tumor tissue, NK cells have several advantages over T cells expressing CARs, like 
spontaneous cytotoxic activity and a different less inflammatory set of cytokines [21]. 
NK cells not only control infections as part of the classical immune response but also protect 
against transformed and potentially malignant cells. Tumors develop out of uncontrollably 
proliferating cells, which are usually the result of mutations. These mutations can occur 
spontaneously upon exposure to certain chemicals or radiation. Given the sheer number of 
cells in the human body the occurrence of transformed cells is unavoidable. Therefore, many 
mechanisms – among them the constant surveillance of NK cells - exist to ensure that these 
cells are recognized and eliminated either by inducing apoptosis or direct killing. The ability 
of NK cells to spontaneously recognize and kill transformed cells is therefore an important 
line of defense against cancer. Briefly, NK cells take part in the defense against infections, the 
regulation of immune responses as well as the surveillance of stressed or transformed cells. 
NK cells exert their immune functions by cellular cytotoxicity, the secretion of cytokines and 
chemokines as well as contact with other immune cells [8]. 
For many NK cell effector functions direct cell contact with its target cell is required. This 
interaction between target cell and effector cell has been termed immunological synapse (IS). 
Formation of a lytic immune synapse provides additional regulatory steps by bringing NK cell 
receptors and their ligands in physical proximity and is critical for directed secretion of 
effector molecules [22-24]. The IS enables the rearrangement of receptors, ligands, adhesion 
molecules, signaling components and effector molecules on and in the NK cell as well as on 
the target cell to enhance signaling between effector and target cell as well as provide a 
direction for the secretion of effector molecules. Briefly, the formation of the synapse starts 
upon contact with the target cell and rearrangement of the actin cytoskeleton. Next, the 
microtubule-organizing centre (MTOC) of the NK cell and the secretory lysosomes are 
polarized towards the IS. Thereafter secretory lysosomes dock with the plasma membrane at 
the IS, before fusing in the final stage with the plasma membrane and releasing their cytotoxic 
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contents. Cytotoxic proteins contained within secretory lysosomes are released towards the 
target cell during this process. The major cytotoxic proteins released by NK cells are perforin 
and granzymes [25]. Perforin creates pores in the membrane of the target cell to facilitate the 
entry of granzymes into the target cell. Granzymes are serine proteases that cleave a variety of 
targets, like caspases, that induce target cell death through apoptosis.  As cytotoxic granules 
fuse with the membrane and undergo exoxcoytosis, the lyososomal protein CD107a is 
incorporated into the NK cell membrane. Hence, NK cell degranulation can be measured by 
incorporation of CD107a in the NK cell membrane [26]. CD107a, also known as Lysosomal-
associated membrane protein 1 (LAMP-1), is found primarily in lysosomal membranes and 
has been reported to protect NK cells during degranulation from self-reactivity [27]. NK cells 
can also use Fas ligand (FasL) or TNF-related apoptosis-inducing ligand (TRAIL), both 
belonging to the TNF family, to induce target cell death by apoptosis. How cytotoxic cells 
detect target cell death and know when to release their target remains still unclear, but there is 
evidence of serial killing by NK cells. Hence, it is likely that a mechanism exists to ensure the 
release of NK cells only upon successful elimination of the target cell.  
A recent study indicated that mechanical force exerted by cytotoxic T lymphocytes (CTL) via 
the immunological synapse contributed to perforin pore formation and that artificially 
increased target cell tension augmented pore formation and killing [28]. While NK cells share 
many features of the IS with CTLs, differences in kinetics and mechanism have been reported 
[29], therefore similar experiments need to be conducted with NK cells to examine the 
influence of mechanical force.   
The main cytokines released by NK cells are the type 1 cytokines interferon gamma (IFN-γ) 
and tumor necrosis factor alpha (TNF-α). NK cell derived IFN-γ provides protection against 
viruses in humans [30] and was shown to control viral replication in vitro [31, 32]. In 
addition, IFN-γ can activate other cell types such as DCs, macrophages, T cells and promote 
upregulation of MHC-1 molecules on other cells [33]. NK cell derived IFN-γ has also been 
reported to improve the outcome of liver fibrosis contributing to organ homeostasis [34]. The 
accumulation of activated TNF-α producing NKp44+ NK cells in the human liver has been 
reported to correlate with liver fibrosis and viral load [35]. Both IFN-γ and TNF-α have been 
reported to aid NK cell cytotoxicity by NF-Kb dependent upregulation of ICAM-1 expression 
on target cells, thereby assisting conjugate formation between NK and target cells [36].   
NK cells might also regulate other cell types as well as other NK cells by cytotoxicity. 
Activated T cells can be eliminated by NK cells to prevent overactivation [37, 38]. It has been 
reported that activated mouse NK cells can be killed by other NK cells after membrane 
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transfer of the NKG2D ligand Rae-1 from tumor cells [39]. Murine NK cells deficient for the 
IFN-a receptor have also been shown to express increased levels of NKG2D ligands and are 
therefore susceptible to killing by other NK cells [40].  
 
2.1.2 NK cell education 
One important step for the understanding of NK cell regulation was the realization that NK 
cells preferentially kill cells with low or no major histocompatibility complex (MHC) class I 
expression that led to the formulation of the “missing-self hypothesis” [41]. The identification 
of MHC class I specific inhibitory receptors supported this concept. These receptors signal 
through an immunoreceptor tyrosine-based inhibitory motifs (ITIMs) in their cytoplasmic tail 
and are phosphorylated upon binding to MHC class I presumably by Src kinases. They can 
recruit and activate phosphatases such as SHP-1/2 and SHIP to the receptor clusters, 
interfering with activating signaling pathways by dephosphorylation. Early studies implied 
that NK cells express at least one inhibitory receptor specific for self MHC-1, but subsequent 
studies found subpopulations without inhibitory receptors for self MHC-1 in mice and 
humans [42, 43]. In addition, NK cells in MHC-1 deficient hosts are not autoreactive. Thus, 
another mechanism has to exist to prevent NK cells lacking inhibitory receptor expression 
from autoreactivity. NK cells lacking inhibitory receptor expression were found to be 
hyporesponsive when triggered. This adaptation of the reactivity of NK cells depending on 
the inhibitory receptor ligand matches is generally referred to as NK cell education and 
assures the self-tolerance of NK cells. Several theories have been proposed to explain this 
process and the evidence so far provides support for different theories. In the “licensing” 
model [44], signaling by inhibitory receptors allows NK cells to gain functional competence 
so that only NK cells with functional inhibitory receptors become mature. In the “disarming” 
model [45], chronic stimulation by activating receptors renders NK cells hyporesponsive or 
anergic. Inhibitory signals could counteract this constitutive activation resulting in functional 
NK cells. As self-specific inhibitory receptors don’t seem to function as an all or nothing 
signal, the “rheostat model” was proposed [46]. In this theory, stronger inhibitory signals 
would increase the functional responsiveness of NK cells.  
Given the available data today, all proposed theories can explain certain aspects of NK cell 
education and are still discussed in the NK cell community [47, 48]. 
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2.1.3 NK cell maturation 
NK cells are – like B and T cells  - derived from common lymphocyte progenitors (CLP) and 
NK cells are thought to develop primarily in the bone marrow. Both cytokines and 
transcription factors drive and control NK cell development. Interleukin 15 (IL-15) is critical 
for the development of NK cells and required constantly during their lifespan [49, 50]. The 
transcription factor PU.1 is important for early NK cell development and Id2 and Tox are 
required for later stages [51] whereas Eomes and T-bet regulate the final stages of NK cell 
development [52].  
According to the expression of surface molecules, NK cell populations have been grouped 
into different maturation stages. There is a developmental relationship between the different 
subpopulations, suggesting a differentiation of mature NK cells starting from CD56bright via 
CD56dim, CD57-, CD62L+, CD94/NKG2A+ to the more differentiated CD56dim, CD57+, 
CD62L-, CD94/NKG2A- NK cells. While CD56bright cells are not very cytotoxic, they are 
especially good at producing IFNγ after stimulation with pro-inflammatory cytokines, such as 
interleukin IL-12 and IL-18. This activity is gradually lost during the differentiation towards 
the more cytotoxic CD56dim, CD57+ NK cells. In contrast, these most differentiated NK cells 
can produce more IFNγ when triggered via activating surface receptors and this IFNγ 
competence has recently been linked to the epigenetic remodeling of the IFNG promoter [53]. 
In addition to the subpopulations defined by these maturation markers, NK cells can be 
grouped by the expression of other surface molecules as well. Indeed, one study with just 37 
parameters [54] found over 30.000 NK cell subpopulations. In addition, NK cell diversity 
increases with age and after viral infections, so this heterogeneity might be beneficial [55].  
 
2.1.4 NK cell memory 
Recent studies have shown that NK cells can also acquire memory or memory-like functions, 
thereby challenging the classical distinction between innate and adaptive. NK cells that 
exhibit a more potent secondary response were first described in a mouse model of delayed-
type hypersensitivity (DTH) using hapten or viral antigens [56, 57]. Recombination-activating 
gene (RAG)-deficient mice, lacking T and B cells, were sensitized with a hapten or a viral 
antigen and showed an NK cell-specific DTH response when challenged later with the same 
antigen. This antigen-specific type of NK cell memory is confined to CXCR6-positive liver 
NK cells [58]. In another form of antigen-specific NK cell memory, the receptor responsible 
for the effect is known. Cytomegalovirus (CMV) infections in mice have been shown to 
induce a rapid and clonal-like expansion of a NK cell subset expressing Ly49H, which 
recognizes the CMV-encoded protein m157 [59].  These NK cell memory subsets show 
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enhanced immune responses upon secondary challenge with CMV. The activating receptor 
DNAX accessory molecule-1 (CD226) cooperates with Ly49H for the expansion of these 
memory NK cells by signaling through Fyn and protein kinase Cη (PKCη) [60].  
CMV infection is also associated with the generation of memory NK cells in humans, where 
the expansion and long-term persistence of NKG2C+ NK cells can be observed [61, 62]. 
However, NKG2C does not seem to be involved in the direct recognition of CMV [63]. 
Interestingly, similar expansions of NKG2C+ NK cells have been observed during and after 
other virus infections, such as hantavirus, HIV and hepatitis B [64], but they were always 
restricted to human CMV-seropositive individuals. 
In vitro exposure of NK cells to a combination of IL-12, IL-15 and IL-18 generates memory-
like cells that show enhanced effector functions [65, 66]. In vivo, inflammation or other 
immune responses could result in the exposure of NK cells to these cytokines. Dendritic cells 
are the main producers of IL-12 and IL-18, thereby regulating NK cells [67]. However, in the 
current situation, it is very difficult to judge how much memory NK cells can contribute to 
immune responses against secondary infections with the same pathogen. 
 
2.1.5 Relation to other ILCs 
In recent years, other immune cells with comparable cytokine-induced responses have been 
identified and therefore NK cells have been reclassified as innate lymphoid cells (ILC). 
Parallel to T cell classifications, three major groups of ILCs have been defined on the basis of 
similarity in their production of signature cytokines, developmental requirements, and 
phenotypic markers. RNA analysis in tonsils revealed four distinct populations corresponding 
to ILC1 cells, ILC2 cells, ILC3 cells and NK cells. [68] All ILC subsets are CD45+ lineage 
negative lymphocytes, meaning that they lack markers for the common lineages including T 
cells, B cells and cells of a myeloid origin. ILCs depend on IL-7 for their development and 
survival and concordantly express the receptor for IL-7 (CD127). Together with ILC1s, NK 
cells constitute group 1 ILCs, which are characterized by their capacity to produce interferon-
γ and their functional dependence on the transcription factor T-bet, similarly to how type 1 
helper T (TH1) cells are defined. 
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2.2 NK cell receptors and signaling 
 
Figure 1. Major activating NK cell receptors, their known ligands and downstream signaling. With permission from 
Watzl: How to trigger a killer [9] 
NK cell activity is tightly regulated by an interplay between activating and inhibitory cell 
surface receptors. With the exception of the Fc receptor CD16, most activating NK cell 
receptors recognize ligands expressed by infected or transformed cells (Fig. 1). Inhibitory 
receptors recognize MHC class 1 molecules. Synergy between activating receptors is 
necessary to overcome inhibitory signals. One additional regulatory mechanism that has been 
described recently is the organization of receptors and signaling components as microclusters 
on the cell membrane. Recent reports indicate these microclusters might play a role in NK cell 
regulation as well. It has been shown that receptor clustering at the lytic synapse is important 
for the generation of robust signaling in NK cells [69]. Altering the membrane organization of 
activating receptors may be important to how NK cell self-tolerance is achieved [70] and 
phosphorylation of the inhibitory KIR2DL1 receptor occurs in signaling microclusters at the 
synapse between an NK cell and its target [71]. The major activating and inhibitory NK cell 
receptors, their known ligands and downstream signaling are summarized in this chapter. 
 
2.2.1 ITAM-associated receptors 
One important receptor-associated signaling motif is the immunoreceptor-tyrosine based 
activation motif (ITAM). ITAMs were described 30 years ago on the basis of their sequence 
homology [72] and consist of paired YxxL/I motifs separated by a defined interval (YxxL/I-
X6-8-YXXL/I). The main activating receptors of T cells and B cells, TCR and BCR, associate 
with partner chains that contain ITAM motifs in their cytoplasmatic tail and therefore 
signaling through ITAMs has been extensively studied in these cell types [73]. 
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In human NK cells, activating killer cell Ig-like receptors (KIR-S), CD94/NKG2C-E, and 
NKp44 associate with DAP12, while NKp46, NKp30, and CD16 pair with CD3ζ and FcεRγ, 
through which they trigger NK cell functions.  
Canonically, upon receptor engagement Src-family kinases (SFK) phosphorylate the two 
tyrosines in the ITAM and these in turn form a binding site for the Src-homology domain 2 
(SH2) domains of the SYK family kinases SYK and ZAP70. Both ZAP70 and SYK possess 
tandem SH2 domains that mediate their specific and selective interaction with doubly 
phosphorylated ITAMs. The combined action of SFK and SYK family kinases is sufficient 
for the full activation of downstream signaling pathways and for eliciting effector responses. 
However, the existence of non-canonical ITAM signaling without the need for SFK has been 
reported in B cells. 
Recruitment of these tyrosine kinases results in phosphorylation of transmembrane adapter 
molecules such as LAT and NTAL as well as phosphorylation of cytosolic adapter molecules 
like SLP-76 and 3BP2. These adapters provide binding sites to many downstream signaling 
molecules and facilitate the assembly and phosphorylation of signaling complexes. These 
include PI3K, PLCγ and Vav2,3.  
 
 
CD16 
In contrast to other activating NK cell receptors, CD16 is a Fc receptor and therefore 
recognizes the Fc part of an antibody. This makes NK cells a versatile tool against a wide 
array of pathogens and malignant cells despite their limited and germ-line coded repertoire of 
activating receptors. In a process called antibody-dependent cellular cytotoxicity (ADCC), 
NK cells recognize target cells whose membrane-surface antigens have been bound by 
specific antibodies.  As many therapies increasingly make us of monoclonal antibodies or 
IVIg, these affect NK cells via engagement of CD16 [74]. CD16 is the only activating NK 
cell receptor that can trigger resting NK cells when stimulated in isolation. Recently, a 
subpopulation of human NK cells has been described that is deficient for the FcεRγ signaling 
adaptor. NK cells lacking FcεRγ display poor cytotoxicity but significantly enhanced IFNγ 
production upon CD16 stimulation [75]. FcεRγ− NK cells have a CD56dim phenotype and the 
existence of this subset is also associated with prior human CMV infection [76]. However, 
these NK cells also demonstrate enhanced responses against other viruses [77]. How the 
selective expression of adapter chains regulates NK cell signaling remains to be investigated. 
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Natural cytotoxicity receptors (NCRs)  
Classically defined as activating NK cell receptors mediating NK cell cytotoxicity and 
production of inflammatory cytokines, the NCR family consists of the three known members 
NKp30, NKp44 and NKp46. NCR’s are expressed on NK cells and subsets of other ILCs, 
some T cell and NKT cell subsets, and can recognize a variety of ligands derived from 
viruses, parasites, bacteria and transformed or malignant cells [78]. NKp46 and NKp30 have 
been reported to bind to several pathogen-derived ligands. For NKp30, two cellular ligands 
have been identified, BAG6 and B7-H6. NKp44 also binds to several pathogen-derived 
ligands and to the cellular ligands PCNA and NKp44L. Some NCR ligands remain to be 
identified. All NCRs rely on adapter chains to activate signaling pathways after receptor 
engagement and – like CD16 - their signaling might be partially regulated by different 
expression of these adapter chains. NKp44 associates with DAP12, while NKp46 and NKp30 
pair with CD3ζ and FcεRγ.  
Despite association with the same adapter chains as CD16, only CD16 is known to trigger 
primary non-activated NK cells when stimulated alone. One explanation for that could be a 
difference in the interaction between CD16 or the NCRs and the adapter chains [79]. A key 
molecule where activating signals converge could be SLP-76 [80], which will be discussed 
later. 
 
2.2.2 NKG2D 
NKG2D is an activating receptor that recognizes cellular ligands on transformed or infected 
cells. These ligands include MICA, MICB and ULBP1-6, which are usually not expressed in 
healthy adult tissue at significant levels that activate NK cells [81]. Expression of these 
proteins can be induced by hyperproliferation, transformation or infection by pathogens [82]. 
In humans, NKG2D is associated with DAP10. DAP10 contains a YINM tyrosine-based 
signaling motif. Upon receptor engagement, Src kinases phosphorylate DAP10 which can 
recruit PI3K or Vav1 through the adapter GRB2. Structural analysis has shown that one 
NKG2D homodimer associates with four DAP-10 chains [83], therefore both pathways could 
be triggered simultaneously by one receptor homodimer.  
 
2.2.3 SLAM-related receptors 
Another group of NK cell receptors is part of the signaling lymphocyte activation molecule 
(SLAM) receptor family. 2B4, NTB-A and CRACC are members of this group expressed on 
human NK cells. These receptors contain immunoreceptor tyrosine-based switch motifs 
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(ITSM) in their cytoplasmatic tail. 2B4 binds to CD48 [84] while NTB-A and CRACC are 
their own ligands and interact in a homophilic manner. CD48 is expressed on all human 
hematopoietic cells. Upon receptor engagement, Src family kinases phosphorylate the ITSM 
motifs leading to the recruitment of small SH2-domain-containing molecules like SAP and 
EAT2. SAP recruits the Src kinase Fyn [85, 86], which can initiate further downstream 
signaling. The motif of these receptors is named a “switch” motif because in the absence of 
SAP they undergo a “switch-of-function” and mediate inhibitory signals [87]. 
 
2.2.4 DNAM-1 and NKp80 
In addition to the previously mentioned groups of activating NK cell receptors there are 
several receptors that also contain tyrosine-based activation motifs. The most prominent 
receptors are DNAM-1 and NKp80. 
Known ligands for DNAM-1 are Nectin-2 (CD112) and PVR (CD155). Both ligands have 
been reported to be upregulated on tumor cells [88, 89]. DNAM-1 has tyrosine-based 
signaling motifs in its cytoplasmic tail and can recruit the Src-family kinase Fyn and PKC 
[90, 91]. DNAM-1 deficiency in mice has been reported to affect the expansion and 
generation of memory NK cells [60].  
NKp80, also known as killer cell lectin-like receptor subfamily F, member 1 (KLRF1), is a 
type II transmembrane C-type lectin-like receptor [92]. NKp80 signals through a hemiITAM 
motif in its cytoplasmatic tail [93, 94]. NKp80 induces NK-cell mediated cytotoxicity and 
cytokine production through interaction with its ligand AICL. Expression of NKp80 
correlates with NK cell maturation in secondary lymphoid tissue and has been proposed as a 
marker of NK cell maturation in tissue [95]. 
 
2.2.5 Inhibitory receptors  
Human NK cells recognize self MHC-1 molecules by killer cell immunoglobulin-like 
receptors (KIR). These receptors transmit inhibitory signals via an immunoreceptor tyrosine-
based inhibitory motif (ITIM). Upon engagement by MHC-1, the ITIM motif is 
phosphorylated presumably by Src kinases followed by recruitment of phosphatases like 
SHP-1, SHP-2 and SHIP [96]. Recruitment of phosphatases interferes with the signaling by 
activating receptors. KIRs have evolved from the Ig-superfamily and consist of type 1 
transmembrane glycoproteins with two or three Ig-like domains and possess either a short or 
long cytoplasmic tail [97, 98]. In humans, the KIR receptors KIR2DL2/2DL3, KIR2DL1, and 
KIR3DL1 are specific for the HLA-C1, HLA-C2, and HLA-Bw4 ligands, respectively [99]. 
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CD94–NKG2A heterodimers belong to the C-type lectin family of receptors. They recognize 
the non-classical MHC molecule HLA-E [100] and signal through ITIMs as well. HLA-E 
binds peptides derived from the leader sequence of classical MHC-1 molecules [101], 
therefore providing NK cells with a mechanism to indirectly monitor the expression of MHC-
1 on target cells.  
 
2.2.6 Common downstream signaling and intersection points 
Many activating signals share common signaling components. All activating receptors or their 
adapters are phosphorylated by Src family kinases. No kinase of this family is essential for 
NK cell functions, but pharmacological inhibition of all Src-family kinases blocks ITAM and 
non-ITAM signaling and therefore NK cell effector functions. NK cells express a large 
number of Src family kinases, including Fyn, Lck, Lyn, Hck, c-Fgr, Src and c-Yes [102-104]. 
SFK can be reciprocally regulated by Csk and CD45. CD45 specifically dephosphorylates the 
C-terminal inhibitory tyrosine of SFK and has been reported to be a critical positive regulator 
of Lck and Fyn in T cells [105]. Csk is thought to be the kinase that phosphorylates the C-
terminal inhibitory tyrosine of SFK, driving SFK towards an inactive state. While deficiencies 
in ZAP70 or SYK will severely impair T cell and B cell functions [106, 107], respectively, 
NK cell maturation and cytotoxic activity are not significantly impaired even when ZAP70 
and SYK are both absent as not all receptors rely on SYK family kinase signaling. But ITAM-
coupled receptors have been reported to be functionally impaired in the absence of SYK 
family kinases [108].  
Two downstream molecules of particular interest for this study are VAV1 and SLP-76 as they 
are phosphorylated upon engagement of several activating NK cell receptors and might 
function as intersection point of activating and inhibitory signals. 
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SLP-76 
 
Figure 2. Structure and interaction partners of SLP-76.  SLP-76 contains inducibly phosphorylated tyrosines in the amino 
(N) terminus, a central proline-rich domain and a carboxy (C)-terminal SH2 domain. These domains mediate binding to 
several other signal-cascade intermediates as shown. ADAP,	 adhesion-	 and	 degranulation-promoting	 adaptor	 protein;	BTK,	Bruton's	tyrosine	kinase;	GADS,	GRB2-related	adaptor	protein;	GRB2,	growth-factor-receptor-bound	protein	2;	ITK,	interleukin-2-inducible	T-cell	kinase;	NCK,	non-catalytic	region	of	tyrosine	kinase;	PLCγ,	phospholipase	Cγ. With 
permission from Koretzky et al., Nat Rev Imm 2006 [109].  
SLP-76 was first described in T cells and plays an important role in TCR signaling but SLP-
76 is highly expressed in spleen, thymus and other peripheral blood leukocytes as well. While 
one earlier study found SLP-76 to be dispensable for NK cell effector functions [110] these 
findings were contradicted in later studies taking advantage of inducible SLP-76 KO mice 
[111] and SLP-76 has been shown to be important for NK cell development, cytotoxicity and 
IFN-γ production [112, 113]. Signaling through SLP-76 by activating receptors is critical for 
NK cell education [114]. 
Phosphorylation of SLP-76 at two tyrosines, Tyr113 and Tyr128, has been proposed as 
intersection point of activating signals by different receptors [80]. It was shown that 
stimulation of the 2B4 receptor resulted primarily in phosphorylation of Tyr113 whereas 
stimulation via NKG2D or DNAM-1 induced phosphorylation of Tyr128. Thus, these 
phosphorylation sites could provide a molecular basis for the synergy of activating NK cell 
receptors. In support of this hypothesis, engagement of CD16 induces the phosphorylation of 
both Tyr113 and Tyr 128 and CD16 alone is sufficient to trigger the activation of resting NK 
cells. SLP-76 functions as an adapter and is known to interact with many other key signaling 
molecules like Vav, p38, Lck, PLCγ to form signaling complexes upon stimulation (Fig. 2) 
[109]. SLP-76 is also critical for T cell activation by the TCR [115] and a homologue 
expressed in B cells termed SLP-65 (encoded by BLNK) important for signaling by the BCR 
[116]. 
Furthermore, SLP-76 has been reported to play an essential role in the formation of 
microclusters surrounding the TCR upon activation [117, 118]. SLP-76 functions as a 
scaffolding protein that can interact with many other proteins. Previously described 
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interactions partners include, but are not limited to Vav1, p38, Itk, Nck, Lck, ADAP, GADS 
and PLCγ [109, 119]. 
 
Vav1 
Vav1 is a member of the Dbl family of guanine nucleotide exchange factors (GEF) for the 
Rho family of GTP binding proteins. Vav1 contributes to the activation of Rho-family 
GTPases like Rac1 and Cdc42 that are important regulators of actin reorganization.  
While NKG2D selectively signals via Vav1 [120], ITAM-based receptors rely more on Vav2 
or Vav3 for their function [121]. NK cells only deficient for Vav1 show an impairment in NK 
cell cytotoxicity [122] but when all three Vav isoforms are absent NK cell functions are 
severely compromised [121]. Vav1 has been described as an intersection point to integrate 
activating and inhibitory signals through regulation of Vav1 phosphorylation levels by Src 
family kinases and the phosphatase SHP-1 [123]. 
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2.3 Schneider cells (S2) 
In synthetic biology, scientists rebuild functional minimal signaling systems which can then 
be easily manipulated to enhance mechanistic understanding. Schneider cells, isolated from 
Drosophila melanogaster embryos in 1972 [124], provide a useful platform for this approach. 
Historically, S2 cells have often been used for large-scale preparative protein expression 
[125-127]. Moreover, elements of the early T cell receptor (TCR) signaling pathway also 
have been expressed in S2 cells in order to investigate the exact specificity of antibodies 
directed against phosphorylation sites in the ITAMs of TCR-CD3 subunits after their 
phosphorylation by the Src family kinases Lck and/or Fyn [128]. They easily take up large 
amounts of DNA enhancing co-transfection while maintaining a reasonably high transfection 
efficiency (about 30%). The evolutionary distant environment should prevent interference of 
Drosophila proteins with the heterologously expressed mammalian signaling system. In 
previous studies, the S2 system was used to investigate signaling of the BCR [129-132] and a 
synthetic approach applied to elucidate TCR and ITAM signaling [133]. Other studies 
employed S2 cells to investigate human transcription factors [134, 135]. For similar reasons, 
Schneider cells were utilized by the Long lab as target cells where only the transfected ligands 
were recognized by NK cells without interference by other mammalian molecules [80, 136]. 
For transient co-transfection experiments in Drosophila Schneider cells, the expression vector 
pRmHa-3 containing an inducible metallothionein promoter [137] was used. Thus, expression 
of the transiently transfected vectors could be induced by non-toxic concentrations of copper 
sulphate. By only transiently transfecting the cells with a sufficient efficiency, there is no 
need for a long selection process to further enrich transfected cells. 
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3 Objective 
The aim of this study is to use a synthetic approach to predict NK cell signaling and verify 
these results in primary human NK cells. Pitfalls of conventional approaches to signaling 
studies that are conducted with inhibitors or by knockdown are often unspecific side-effects. 
Redundancy of many proteins like Src family kinases provide challenges to signaling studies 
as well. Furthermore, signaling processes are very complex and often overlapping in vivo and 
important components of an investigated pathway could easily be missed. Thus, rebuilding a 
functional pathway by a synthetic approach could help our understanding of essential 
components of NK cell signaling. A useful tool for this approach that has been previously 
described in the literature are the evolutionary distant S2 cells that can co-express many 
transiently transfected proteins at once. Together with conventional signaling studies in 
primary cells to validate results obtained in the artificial S2 system, this could be a powerful 
approach to investigate NK cell signaling. 
Thus, we aimed to recreate a functional minimal NK cell signaling pathways utilizing S2 
cells. This pathway should be inducible by cross-linking or engagement with natural ligands. 
Additionally, we wanted to examine possible intersection points for inhibitory and activating 
signals by recreating respective pathways in S2 cells. Obtained results and postulated 
pathways should be validated in primary NK cells by use of inhibitors.  
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4 Results 
4.1 Transient Co-transfection in Schneider cells 
 
 
 
Figure 3. High co-transfection rate of multiple genes in transiently transfected Schneider cells. (A) Schneider S2-cells 
were co-transfected with plasmids coding for 2B4, CRACC, DAP10, DAP12, CD3ζ (CD247), SLP-76, SYK and GFP. 
Expression was induced by CuSO4. After 36-48 hours GFP- and GFP+ cells were enriched by cell sorting and analyzed by 
FACS for expression of GFP, 2B4 and CRACC. Results are representative of three independent experiments. (B) Western 
blot analysis of co-expressed proteins in the total cellular lysate of transiently transfected S2 cells from (A) enriched for GFP- 
and GFP+ by cell sorting. GAPDH was used as a loading control. Results are representative of five independent experiments. 
To test for the high co-transfection efficiency in S2 cells, S2 cells were transiently transfected 
with plasmids encoding for GFP, SLP-76, SYK, Fyn, DAP10, DAP12, SHP-1 and for the 
receptors 2B4 and CRACC. This resulted in about 30% GFP positive cells, which were then 
sorted by FACS as GFP+ and GFP-. Analysis of protein expression by Western Blot and 
FACS clearly indicated that only GFP+ cells expressed high levels of all the transfected 
proteins while there were almost undetectable levels of the transfected proteins in GFP- cells 
(Fig. 3). FACS analysis of 2B4 and CRACC confirmed surface expression of both receptors 
and revealed that most cells co-expressed both receptors. This demonstrates that transfected 
S2 cells take up all available plasmids and subsequently co-express many heterologous 
proteins transiently with a reasonably high efficiency. Furthermore, using GFP as a marker, 
we were able to enrich the co-transfected cells by sorting. Thus, the S2 cell system provides a 
suitable platform for the setup of an artificial signaling system that is easy to manipulate as 
already demonstrated by others [129-132]. 
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4.2 Limitations of the Schneider cell system 
4.2.1 Src-kinases are constitutively active in the S2-system 
 
 
Figure 4. Src kinases are constitutively active in the S2 system.  (A) S2 cells were co-transfected with combinations of 
CD16, CD3ζ and Fyn and analyzed by Western Blot as described before. (B) S2 cells were co-transfected as in (A) and 
incubated with isotype control (IgG) or CD16 specific antibodies (3G8) on ice before cross-linking for 2’ at 28°C with goat-
anti-mouse IgG. Treatment with H2O2/Pervanadate was used to induce maximal phosphorylation. Phosphorylation of CD3ζ 
was analyzed by Western Blot. (C) S2 cells were co-transfected with 2B4 alone or 2B4 and Fyn and treated as in (B). (D) S2 
cells were co-transfected with CD16 alone or CD16 and CD3ζ (CD247). Membrane expression of CD16 was analyzed by 
FACS (isotype control in red, specific CD16 staining in blue). 
To test the capabilities of the S2 system to reconstruct a minimal signaling pathway, we 
started with the co-expression of CD16 and its associated adapter chain CD3ζ or 2B4 together 
with the Src kinase Fyn, respectively (Fig 4). We observed substantial constitutive 
phosphorylation of the CD3ζ chain and the 2B4 cytoplasmatic tails when Fyn was co-
expressed. While CD3ζ phosphorylation by Fyn was independent of CD16 expression, 
membrane expression of CD16 was only detected when co-expressed with CD3ζ. As reported 
by others [138], CD3ζ is necessary for CD16 membrane expression similar to human immune 
cells. 
Ideally, the minimal signaling system would be inducible by cross-linking the expressed 
receptors with specific antibodies to investigate the interaction of different receptor signaling 
pathways. Therefore, we cross-linked CD16 co-expressed with CD3ζ and Fyn or 2B4 co-
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expressed with Fyn. Cross-linking of the receptors did not result in increased phosphorylation 
of their respective signaling motifs.  
 
4.2.2 DPI-experiments did not result in an inducible system 
 
Figure 5. Pre-treatment with DPI reduced autophosphorylation. (A) S2 cells were transiently co-transfected with the 
indicated proteins as described before and pretreated with DPI for one hour before harvesting. (B) S2 cells were co-
transfected as before with the indicated proteins. Then the cells were cross-linked as described before with specific 2B4 
antibody (C1.7) or isotype control (IgG). 
The activity of Src kinases is regulated by phosphorylation and dephosphorylation of 
activating and inhibitory tyrosines. Like other studies before, we observed constitutive 
phosphorylation and activation of Fyn [129]. One reason for that could be the missing activity 
of inhibitory phosphatases. Protein tyrosine phosphatases (PTP) have been reported to be 
regulated by the redox equilibrium inside the cells. H2O2 production leads to the oxidation of 
a reactive cysteine in the catalytic center of the PTP and therefore reversible inhibition of its 
enzymatic activity. Additionally, high H2O2  levels have been reported to directly activate 
SFK [139]. Rolli et al reported elevated H2O2  production in S2 cells in line with their 
phagocytic activity [129]. H2O2 production can be inhibited by diphenylene iodonium (DPI), 
an inhibitor of flavoproteins like the NADPH oxidase. Therefore, we pretreated the cells with 
DPI before harvesting as described by others. Another well described substrate of Fyn is 
Vav1. We observed Vav1 phosphorylation upon co-expression with Fyn in S2 cells. (Fig. 
5A). DPI pretreatment of cells did reduce the constitutive phosphorylation of Fyn itself and 
Fyn-mediated Vav phosphorylation upon co-expression in S2 cells (Fig. 5A).  
Pretreatment with DPI did show decreased phosphorylation of 2B4 by Fyn upon co-
expression, but did not show an increase in 2B4 phosphorylation in combination with cross-
linking of the 2B4 receptor by a specific antibody compared to isotype control (Fig. 5B).  
Thus, we could decrease the constitutive activity of Fyn by treatment with DPI, but could not 
induce its activation by cross-linking of co-expressed receptors like 2B4. This is in line with 
previous studies that were also not able to recreate an inducible pathway in S2 cells [129].  
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4.2.3 Trying to reconstruct a 2B4 minimal signaling pathway 
 
Figure 6. Co-expression of SAP does not affect 2B4 or Vav1 phosphorylation. S2 cells were co-transfected as described 
before with the indicated proteins and analyzed by Western Blot. 
As we are trying to recreate a minimal signaling pathway it could be the case that essential 
signaling molecules are missing to induce a significant increase in phosphorylation after 
receptor cross-linking. Therefore we co-expressed several NK cell signaling adapters that 
have been reported to play important roles in early signaling of the NK cell receptors 2B4 and 
CD16, respectively. For 2B4 this includes the adapter protein SAP, which binds and recruits 
the Src kinase Fyn to the cytoplasmatic ITSM motifs of 2B4. In patients suffering from X-
linked lymphoproliferative disease (XLP1), SAP is nonfunctional, not only abolishing the 
activating function of 2B4, but rendering this receptor inhibitory [87]. Another important 
adapter that has been reported to recruit Vav1 to 2B4 upon receptor activation is 3BP2. Co-
expression of 2B4, Fyn and Vav1 together with SAP did not result in increased 
phosphorylation of 2B4 or Vav1 (Fig. 6) in various combinations. The absence of 2B4 even 
increased Fyn-dependent Vav1 phosphorylation, presumably because it’s the only substrate 
for Fyn when 2B4 is not co-expressed. Additional co-expression of 3BP2 and/or LAT in 
various combinations or exchanging SAP for EAT2 did not affect phosphorylation levels of 
2B4 or Vav1 either (data not shown).  Pre-treatment with DPI or cross-linking did not 
significantly affect phosphorylation levels either (data not shown).  Thus, our attempts to 
reconstruct a functional minimal signaling pathway dependent on co-expression or even 
activation of the 2B4 receptor were not successful. SFK phosphorylated every co-expressed 
substrate and their activity was not affected or regulated by co-expression with other 
components of the 2B4 pathway in S2 cells. 
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4.2.4 Expression of phosphatases 
 
Figure 7. Co-expression of SHP-1 leads to dephosphorylation of Vav1, but not CD3ζ or SLP-76. (A) Vav1 and Fyn were 
co-expressed in S2 cells with or without SHP-1 and Vav1 phosphorylation was detected by WB. (B) CD3ζ and Fyn were co-
expressed in S2 cells with or without SHP-1 and CD3ζ phosphorylation was observed by WB. (C). CD3ζ, SYK and SLP-76 
were co-expressed in S2 cells with or without SHP-1 and SLP-76 phosphorylation was detected by WB.  
Phosphatases play a prominent role in NK cell signaling by dephosphorylation of activating 
signaling molecules thereby interfering with activating signals. In a previous study, co-
expression of the phosphatase SHP-1 in S2 cells could successfully counteract 
phosphorylation by SYK and Src kinases [129]. To investigate if co-expression of SHP-1 in 
S2 cells could lead to dephosphorylation of other co-expressed signaling components in S2 
cells, we co-expressed SHP-1 in different combinations of the previously observed 
combinations inducing constitutive phosphorylation. Thus, we co-expressed SHP-1 with 
Vav1 and Fyn (Fig. 7A). This decreased the observed phosphorylation of Vav1 on the 
activating tyrosine Y174 significantly. In contrast, the phosphorylation of CD3ζ by Fyn was 
not affected by co-expression of SHP-1 (Fig. 7B). SYK-mediated and ITAM-dependent 
phosphorylation of SLP-76 was also not affected by co-expression of SHP-1 (Fig. 7C).  
Phosphatases are recruited by inhibitory receptors containing ITIM motifs, therefore it might 
be possible that the presence of an ITIM motif could enhance SHP-1 phosphatase activity. 
Co-expression of KIR2DL1, an inhibitory NK cell receptor containing ITIM motifs in its 
cytoplasmatic tail, did not enhance SHP-1 activity in different combinations or when cross-
linked by specific antibodies (data not shown). Therefore, SHP-1 demonstrated substrate 
specificity as well as constitutive activity upon co-expression in S2 cells.  
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4.3 ITAM – SYK – SLP-76 
4.3.1 ITAM-expression results in SYK activation and SLP-76 phosphorylation 
 
Figure 8. SLP-76 phosphorylation in the presence of SYK and ITAM-containing receptors. S2-cells were co-transfected 
with the indicated proteins. Equal numbers of FACS-enriched GFP+ cells were analyzed by Western Blot for SLP-76 
phosphorylation and expression of the transfected proteins. Expression of NKp80 and CRACC was verified by FACS 
analysis (Supplementary data). Results are representative of at least 5 independent experiments. 
We then used the S2 cell system to rebuild an ITAM-based signaling pathway resulting in 
SLP-76 phosphorylation. Expression of SLP-76 alone in S2 cells did not result in its 
phosphorylation, demonstrating that Drosophila kinases do not significantly phosphorylate 
human SLP-76 (Fig. 8). Co-expression of SYK also did not result in SLP-76 phosphorylation. 
However, co-expression of SLP-76 and SYK together with ITAM bearing signaling adapters 
such as CD3ζ, FcεRγ or DAP12 induced phosphorylation of SLP-76 at tyrosines Y113 and 
Y128. Therefore we could identify a non-canonical pathway for ITAM-mediated SYK 
activation that does not rely on SFK. This pathway is very similar to a previously described 
pathway utilizing transiently co-transfected S2 cells. In this earlier study, the more B cell 
specific ITAM-containing Ig-α was co-expressed with SYK and the B cell adapter SLP-65, a 
homologue of SLP-76. Co-expression of all three molecules in S2 cells resulted in SLP-65 
phosphorylation. We could replicate these results with more NK cell specific signaling 
components. Moreover, we compared the ability of other non-ITAM receptors to activate 
SYK without the co-expression of SFK.  Co-expression of 2B4 and CRACC, which both 
carry ITSM motifs in their cytoplasmatic tail, with SLP-76 and SYK did not lead to SLP-76 
phosphorylation. Co-expression of NKp80, which carries a hemiITAM motif, with SLP-76 
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and SYK also did not induce SLP-76 phosphorylation. Thus, only ITAM-containing adapters 
were able to enhance SYK activity and result in SLP-76 phosphorylation. Taken together, we 
could confirm and expand the earlier report of an SFK-independent ITAM-SYK-SLP-76/65 
pathway in S2 cells with signaling components expressed by NK cells. 
 
4.3.2 ITAM-activation of other kinases 
 
Figure 9. Ability of other kinases to phosphorylate SLP-76 in S2 cells when CD3ζ is co-expressed.  S2-cells were co-
transfected with the indicated proteins. Equal numbers of FACS-enriched GFP+ cells were analyzed by Western Blot. 
Representative of three independent experiments.  
Next we tested the ability of other kinases to phosphorylate SLP-76 when co-transfected with 
an ITAM-containing protein. Therefore, we co-transfected S2 cells with CD3ζ and SLP-76 
and the kinases SYK, ZAP70, Fyn and Csk. SYK induced the strongest phosphorylation of 
SLP-76. While the SYK-family kinase ZAP70 could phosphorylate SLP-76 to a lesser extent, 
no phosphorylation was detectable when the Src-family kinases Fyn or the kinase Csk were 
co-transfected (Fig 9). In addition, we analyzed the phosphorylation status of CD3ζ. Here we 
observed that Fyn induced by far the highest level of CD3ζ phosphorylation, while SYK and 
ZAP70 phosphorylated CD3ζ at lower levels. SYK phosphorylated CD3ζ more than ZAP70. 
Csk did not induce any detectable CD3ζ phosphorylation. 
SLP-76 is a known substrate of SYK and ZAP70. In the S2 system, both SYK kinases 
demonstrated the ability to phosphorylate SLP-76 upon co-expression with CD3 ζ. However, 
SYK is significantly more activated than ZAP70 in this setting.   
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4.3.3 Mutations of SYK and CD3ζ 
 
Figure 10. Structure and investigated mutations of SYK kinase. S2-cells were co-transfected as described before with 
GFP, SLP-76 and mutations or WT of CD3ζ and SYK. (A) Analysis of SLP-76 phosphorylation upon co-expression of GFP, 
SLP-76, CD3ζ and either wildtype (wt) SYK or the indicated SYK SH2-domain mutants. All Western Blots are 
representative of at least three independent experiments. (B) SYK mutations utilized in (A). With permission from Rolli et al. 
Mol Cell 2002 [129]. (C) Analysis of SLP-76 phosphorylation upon co-expression of GFP, SLP-76, SYK and either wildtype 
(wt) CD3ζ or the indicated CD3ζ ITAM-mutants. (D) SLP-76 phosphorylation was analyzed in GFP+ cells upon treatment 
with the SYK-family kinase inhibitor SYKIV, the Src-family kinase inhibitor PP1 or DMSO as a carrier control.  
To further investigate the conditions necessary for SYK activation and subsequent 
phosphorylation of SLP-76, we made use of the easy manipulation of the S2-system. 
Canonically, the SH2 domains of SYK can bind to phosphorylated ITAM motifs. 
Using CD3ζ mutants we observed no SLP-76 phosphorylation when all tyrosines of the 
ITAMs were replaced by phenylalanine, whereas the presence of a single intact ITAM was 
sufficient to result in some SLP-76 phosphorylation (Fig. 10C). Similarly, using SYK mutants 
we found that SLP-76 phosphorylation was dependent on both SH2 domains, as we did not 
detect any phosphorylation when the N-terminal SH2 domain was deleted or the N-terminal 
or the C-terminal SH2 domain was inactivated by a point mutation (Fig. 10A, B). These data 
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demonstrate that the minimal signaling pathway in S2 cells still relies on the canonical 
interaction of the SYK SH2 domains with the (phosphorylated) tyrosines of the ITAM despite 
being independent of Src-family kinases. 
To further explore the involvement of SYK and Src-family kinases we used pharmacological 
inhibitors during the co-expression of CD3ζ, SYK and SLP-76. Syk Inhibitor IV (SYKIV), 
(or BAY 61-3606 or CAS 732938-37-8), is a cell-permeable, ATP-competitive, reversible, 
and highly selective inhibitor of SYK tyrosine kinase activity. SYKIV does not affect Src 
kinase activity according to in vitro assays conducted by the manufacturer. Its specificity 
targeting SYK kinase activity over ZAP70 has been demonstrated before [140]. Blocking 
SYK kinase activity by the inhibitor SYKIV in the S2 cells completely blocked the SLP-76 
phosphorylation (Fig. 10D), demonstrating that the kinase activity of co-transfected SYK is 
essential for this minimal signaling pathway. The Src Inhibitor PP1 (or CAS 172889-26-8) 
controls the biological activity of Src family kinases. This small molecule inhibitor primarily 
inhibits SFK while affecting the activity of other kinases only at much higher concentrations 
according to the manufacturers in vitro assays. Blocking Src-family kinases with the inhibitor 
PP1 in this experiment did not impact SLP-76 phosphorylation, additionally excluding the 
possibility that Drosophila Src-related kinases may be involved. 
 
 
4.3.4 SYK vs. ZAP70 activation 
 
 
Figure 11. ZAP70 but not SYK is dependent on Src kinases for ITAM-mediated activation. SLP-76, Fyn and CD3ζ 
were co-expressed with either SYK or ZAP70 in S2 cells as described before. Cells were treated with the indicated inhibitors 
or DMSO control for one hour before harvesting. Phosphorylation and expression of proteins was observed by WB.  
The canonical ITAM pathway is initiated by Src family kinases that phosphorylate the ITAM 
motif, therefore providing binding sites for the SH2 domains of SYK and ZAP70. This 
activates SYK and leads to phosphorylation of its targets. To test if increased ITAM 
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phosphorylation also leads to increased activation of SYK and therefore increased 
phosphorylation of SLP-76 in S2 cells, we co-expressed CD3ζ, SYK or ZAP70 and SLP-76 
with the Src family kinase Fyn (Fig. 11). Co-expression of Fyn clearly enhanced 
phosphorylation of CD3ζ in both setups. Of note, co-expression of Fyn did result in SYK 
activation without the need for co-expression of CD3ζ. However, co-expression of Fyn 
seemed to enhance SLP-76 phosphorylation more in the presence of ZAP70 than in the 
presence of SYK. To investigate this difference in activation by Fyn, we treated the S2 cells 
with specific inhibitors as before. Additionally to SYKIV, we used the SYK kinase inhibitor 
SYKII. SYKII is a cell-permeable pyrimidine-carboxamide compound that acts as a potent, 
selective, reversible, and ATP-competitive inhibitor of SYK while affecting ZAP70 and other 
kinases only at much higher concentrations (manufacturers datasheet). In addition to PP1, we 
used the SFK inhibitor PP2 as well. PP2 is a potent, reversible, ATP-competitive, and 
selective inhibitor of the Src family of protein tyrosine kinases that does not significantly 
affect the activity of ZAP70 and other non-Src family kinases (manufacturers datasheet). 
Further confirming this regulation of ZAP70 by Fyn, pretreatment with SYK inhibitors SYKII 
and SYKIV decreased SLP-76 phosphorylation more when SYK was co-expressed, whereas 
Src kinase inhibitors PP1 and PP2 affected SLP-76 phosphorylation more when ZAP70 was 
co-expressed instead of SYK (Fig. 11).   
Therefore, this experiment demonstrates that both SYK and ZAP70 can be activated by co-
expression of Fyn. However, the activation of ZAP70 seemed to be more dependent of kinase 
activity of SFK than SYK. 
4.3.5 Co-expression of Vav1 enhances SLP-76 phosphorylation 
 
Figure 12. Co-expression of Vav1 enhances SLP-76 phosphorylation. S2 cells were transiently co-transfected as 
described before with CD3ζ, SYK and SLP-76 or CD3ζ, SYK, SLP-76 and Vav1. (A) SLP-76 phosporylation and protein 
expression was analyzed by WB. (B) SLP-76 phosphorylation was quantified using Image J software (Version 1.47v). The 
integrated density of each band was measured using the gel analysis function of ImageJ and normalized to SLP-76 using 
ImageJ.  N=3. Statistical analysis was performed using unpaired t-test. 
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A well known interaction partner of SLP-76 is Vav1 [109], which also plays a central role in 
NK cell signaling [123]. We observed enhanced phosphorylation of SLP-76 when the 
previously described minimal signaling pathway of CD3ζ, SYK and SLP-76 was co-
expressed together with Vav1 (Fig. 12). Presumably, binding of Vav1 protects SLP-76 against 
dephosphorylation by phosphatases. Vav1 itself was also phosphorylated in this setting, but 
this phosphorylation was independent of CD3ζ expression (data not shown).   
 
4.3.6 CD45 and Csk control ZAP70 via Fyn 
 
Figure 13. Csk and CD45 can control SYK and ZAP70 activation via Fyn. (A) S2 cells were co-transfected with the 
indicated proteins and analyzed for SLP-76 phosphorylation and protein expression by WB as before. (B) Quantification of 
SLP-76 phosphorylation normalized to SLP-76 expression and lane 3 with CD3ζ, Fyn, SYK and SLP-76 (left) or lane 10 
with CD3ζ, Fyn, ZAP70 and SLP-76 (right). Expression of CD45 was verified by FACS and expression of PAG was not 
detectable. (Supplementary results).  N=2 for left side (SYK), N=3 for right side (ZAP70) 
																													+	
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Src kinases can be controlled by Csk and CD45 [141]. Csk phosphorylates inhibitory 
tyrosines on SFK, thus inhibiting kinase activity. Csk is recruited to the membrane by the 
adapter protein PAG [141]. Csk, via its SH2 domain, constitutively associates with tyrosine-
phosphorylated PAG, a lipid raft targeted transmembrane adapter protein [142, 143]. PAG 
expression should therefore also affect SFK function  [144].  Upon TCR stimulation, PAG is 
transiently dephosphorylated, thereby releasing Csk from the plasma membrane  [145, 146]. 
CD45 dephosphorylates inhibitory tyrosines and might be necessary for full SFK activation. 
In a similar setup expressing CD3ζ, Lck and ZAP70 in HEK cells, a combination of Csk, 
PAG and CD45 was shown to control Lck and ZAP70 activity [141]. Therefore, we tried co-
expressing Csk, PAG and CD45 with either CD3ζ, Fyn, SYK and SLP-76 or CD3ζ, Fyn, 
ZAP70 and SLP-76 to investigate if this affects SLP-76 phosphorylation (Fig. 13). Co-
expression of Csk decreased SLP-76 phosphorylation for both SYK and ZAP70. However, 
co-expression of PAG did not further decrease the observed SLP-76 phosphorylation. Co-
expression of CD45 did not affect SYK-mediated SLP-76 phosphorylation when activated by 
co-expression of CD3ζ and Fyn, but increased ZAP70-mediated SLP-76 phosphorylation in 
the same setup. Additionally, co-expression of CD45 seemed to counteract the inhibition of 
both SYK and ZAP70 activation by Csk.  
Despite our attempts to normalize protein expression between samples when a different 
number of plasmids was co-transfected by including empty pD-vector, we observed stronger 
expression of SLP-76, SYK and ZAP70 when co-expressed with fewer proteins in this 
experiment (Fig. 13A). The differences in expression of SLP-76 were taken into account by 
normalization of p-SLP-76 to SLP-76 for the quantification (Fig. 13B). Thus, the reduced 
phosphorylation of SLP-76 upon co-expression with Csk for both SYK and ZAP70 could be 
attributed to their reduced expression. However, additional expression of CD45 together with 
Csk and PAG in the sample containing the most co-transfected proteins in this experiment 
showed increased phosphorylation of SLP-76. Therefore at least an activating role of CD45 is 
likely despite the reduced expression levels of SYK and ZAP70. 
This experiment is only representative of 2 independent experiments; therefore no statistical 
analysis was possible. 
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4.4 Primary and activated NK cells  
4.4.1 ITAM-receptor cross-linking leads to SYK and Src dependent SLP-76 
phosphorylation in NK cells 
 
Figure 14. SLP-76 is phosphorylated in primary and activated NK cells after cross-linking of ITAM-associated 
receptors. (A) IL-2 activated expanded human NK cells were pre-incubated with the mAbs specific to the indicated 
receptors or an isotype control for 30’ on ice, followed by cross-linking with secondary goat F(ab’)2 anti-mouse IgG at 37°C 
for 2 min. Cell lysates were analyzed by Western Blot for SLP-76 phosphorylation. (B) Freshly isolated, resting human NK 
cells were pre-incubated with the indicated inhibitors or DMSO control for 30 min at 37°C followed by incubation with 
mAbs specific to the indicated receptors or an isotype control for 30 min on ice, followed by cross-linking with secondary 
goat F(ab’)2 anti-mouse IgG at 37°C for 2 min. Cell lysates were analyzed by Western Blotting for SLP-76 phosphorylation. 
All Western Blots are representative of at least three independent experiments and donors. 
Our previous results would predict SLP-76 phosphorylation in a SYK-dependent manner after 
engagement of ITAM-coupled receptors in NK cells.  
To test for the induction of SLP-76 phosphorylation in human NK cells we first used IL-2 
activated, cultured human NK cells and stimulated different activating receptors by antibody-
mediated cross-linking. We observed phosphorylation of SLP-76 at both tyrosines (Y113 and 
Y128) after stimulating CD16, NKp30, NKp44 or NKp46, all of which are associated with 
ITAM-bearing adapter chains (Fig. 14A). Stimulation of NKp80, which signals via a hemi-
ITAM, did not result in detectable SLP-76 phosphorylation, whereas the ITSM-containing 
2B4 receptor could induce strong SLP-76 phosphorylation at both tyrosines in activated NK 
cells. Next, we used pharmacological inhibitors to test which signaling pathways are involved 
in the SLP-76 phosphorylation. In freshly isolated, resting human NK cells, triggering of 
CD16, NKp30 and NKp46 also resulted in SLP-76 phosphorylation (Fig. 14B). This was 
blocked by inhibiting SYK or Src-family kinases, suggesting that in these cells the canonical 
ITAM-based signaling pathway is operational.  
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Figure 15. Stimulation of CD16 and NKp44 in activated NK cells. IL-2 activated and expanded NK cells were pre-
incubated with mAbs specific to either (A) CD16 or (B) NKp44 or an isotype control for 30’ on ice, followed by cross-
linking with secondary goat F(ab’)2 anti-mouse IgG at 37°C for 2 min. Cell lysates were analyzed by Western Blot for SLP-
76 and ERK phosphorylation.  
To further confirm the results obtained in primary rested NK cells and investigate possible 
differences in signaling, we stimulated IL-2 activated, cultured human NK cells via CD16 
(Fig. 15A, Fig. 16) or NKp44 (Fig. 15B, Fig. 17) with cross-linking by specific antibodies. 
The presence of inhibitors specific for SYK kinases, SYKII and SYKIV, decreased the 
phosphorylation of SLP-76 upon receptor cross-linking by both receptors significantly. 
Inhibitors specific for Src family kinases, PP1 and PP2, also decreased SLP-76 
phosphorylation levels upon receptor engagement of CD16 or NKp44.  
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Figure 16.Quantification of CD16 stimulation from Fig. 15A. The protein bands were quantified using Image J software 
(Version 1.47v). The integrated density of each band was measured using the gel analysis function of ImageJ and normalized 
to SLP-76 and to the DMSO-treated stimulated control. N=2. 
 
 
   
Figure 17. Quantification of NKp44 stimulation from Fig. 15B. The protein bands were quantified using Image J software 
(Version 1.47v). The integrated density of each band was measured using the gel analysis function of ImageJ and normalized 
to SLP-76 and to the DMSO-treated stimulated control. N=3. Statistical analysis was performed by one-way ANOVA and 
stars indicate significant differences to DMSO-treated stimulated control.  
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4.4.2 Establishing Phosflow 
 
 
Figure 18. Differential expression of SYK kinases in human immune cells. Human PBMCs were analyzed by 
intracellular staining for expression of SYK and ZAP70. PBMCs were additionally stained for expression of CD3, CD19 and 
CD56 to identify NK, T and B cells. Expression of SYK and ZAP70 in (A) NK cells (CD3-CD56+), (B) T cells 
(CD3+CD56-) and (C) B cells (CD3-CD19+).  Gating on immune subpopulations as depicted in supplementary results. 
The S2 results indicated that ZAP70 activation relies more on SFK than SYK activation (Fig. 
11). While NK cells are known to express both SYK and ZAP70, T cells express only ZAP70 
and B cells express only SYK. Thus, it would be a nice validation to stimulate these three cell 
types in the presence of SFK inhibitors and investigate possible differences in SLP-76 or 
SLP-65 phosphorylation. SLP-65 is the homologue of SLP-76 expressed in B cells [109]. 
Using intracellular flow cytometry with phospho-specific antibodies (Phosflow), it should be 
possible to analyze all three cell types in the same sample of freshly isolated, rested human 
PBMCs without the need for further isolation or separation.   
First we examined the expression of SYK and ZAP70 by intracellular flow cytometry in NK 
cells, T cells and B cells (Fig. 18). As described in the literature [147] we found that NK cells 
are mostly double positive for both SYK and ZAP70, whereas T cells or B cells express only 
ZAP70 or SYK, respectively. Thus, comparing the sensitivity of these three cell types to Src 
and SYK kinase inhibitors upon ITAM-dependent stimulation might provide insights into 
differential regulation of SYK and ZAP70 by Src family kinases. 
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Figure 19. Preliminary flow cytometry results to establish Phosflow. Primary, rested human PBMCs were incubated on 
ice for 30 min with antibodies specific for CD3 (UCHT1), CD28, CD16 (3G8) or isotype control (MOPC-21) as indicated. 
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Cells were washed and subsequently incubated with secondary goat-amti-mouse and/or IgM as indicated for 15’ on ice. To 
induce cross-linking, the cells were incubated for 2’ at 37°C and immediately fixed. To induce maximal phosphorylation, 
cells were treated with H2O2/pervanadate for 2’ at 37°C- Staining of surface markers and intracellular staining for SLP-76 
and/or SLP-65 phosphorylation was performed according to the manufacturers protocol. Lymphocytes were identified by 
FSC/SSC, NK cells as CD3-CD56, T cells as CD3+CD56- and B cells as CD3-CD19+. For percentage of positive cells see 
Table 1.   Table	1:	Percentage	of	p-SLP-76/65	positive	cells	
   
 
        
SLP-
76 
SLP-
65 
NK 
cells 
T 
cells 
B 
cells 
IgG  CD16 CD3/CD28 IgM H2O2   Y128 Y84       
               0,29 0,19 2,3 
               40,6 0,41 19,6 
               0,16 17,9 2,05 
               1,77 0,72 19,5 
               32,3 16 29 
               0,28 0 8,63 
               28 16,2 30,3 
               74,2 46,2 63,6 
               0,44 0,09 31,2 
               78,6 50,2 77,7 
 
To establish intracellular flow cytometry with phospho-specific antibodies in primary human 
PBMCs, we first stimulated the populations of interest alone or in different combinations. 
Additionally, the cells were treated with H2O2/pervanadate as a positive control (Fig. 19 and 
Table 1). Furthermore, we used antibodies specific for p-SLP-76 (Y128) or p-SLP65 (Y84) 
alone or in combination to test their specificity. Ideally, it would be possible to stimulate NK, 
B and T cells in the same sample to investigate the effects of Src and SYK inhibitors on the 
different cell types. Therefore we tested the specificity of the stimulation as well as the SLP-
76 and SLP-65 phospho-specific antibodies in a preliminary experiment. Stimulation of the 
CD16 receptor by cross-linking led to a significant increase in p-SLP-65/76 positive cells 
both in the NK cell and the B cells population. Cross-linking of CD3 and CD28 only 
increased the percentage of p-SLP-65/76 positive T cells confirming a specific stimulation. 
Stimulation of B cells by IgM only increased the percentage of p-SLP-65/76 B cells. To test 
the specificity of p-SLP-76 and p-SLP-65, both conjugated to the same fluorophore AF647, 
we stimulated PBMCs by cross-linking of CD16, CD3 and CD28 and stained with p-SLP-65 
and p-SLP-76 alone or in combination as before. We observed an increase of cells positive for 
p-SLP-76 in all three populations without p-SLP-65, indicating either unspecific binding or 
the expression and phosphorylation of SLP-76 in B cells. Of note, recent studies reported the 
expression of SLP-76 in some B cell subpopulations associated with leukemia [148]. Using 
only p-SLP-65 while stimulating all three cell types in the same sample increased the 
percentage of p-SLP-65 positive B cells. To further confirm these results, we stimulated the 
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cells with H2O2 /pervanadate to induce maximal possible phosphorylation. All three cell-types 
showed increased binding to p-SLP-76 alone upon H2O2 /pervanadate stimulation but only B 
cells showed binding to p-SLP-65 alone. Using both p-SLP-76 and p-SLP-65 antibodies 
further increased the percentage of positive B cells compared to p-SLP-76 or p-SLP-65 alone 
while not significantly increasing the percentage of positive NK cells or T cells compared to 
SLP-76 alone. To summarize, B cells and T cells can be stimulated specifically by cross-
linking CD3/CD28 and IgM and this stimulation simultaneously analyzed by Phosflow, 
respectively. Given the unspecific binding of p-SLP-76 to B cells and their stimulation by 
CD16, it was not possible to stimulate all three cell types in the same sample. Thus, we 
stimulated NK cells and T cells in one sample and B cells in a separate sample while still 
using PBMCs from the same donor and using the same inhibitor stocks on the same day to 
gain comparable results. 
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4.4.3 Phosflow: PBMC stimulation with inhibitors 
 
Figure 20. Inhibitor treatment revealed differential requirements for SFK in NK, T and B cells. Primary, rested human 
PBMCs were stimulated with antibodies specific for CD3 (UCHT1), CD16 (3G8) or isotype control (MOPC-21) by cross-
linking with secondary goat-anti mouse for 2’ at 37°C in the presence of inhibitors or DMSO as before. Representative 
FACS-analysis of PBMCs stimulated with antibodies inducing NK, T or B cell activation via ITAM-coupled receptors or 
isotype control.  
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Figure 21. Quantification of Phosflow results from Fig. 18. N=3 for NK and T cells, N=1 for B cells. 
 
Next, we investigated the phosphorylation of SLP-76 and SLP-65 in NK and T or B cells in 
the presence of inhibitors specific for Src family and SYK kinases. Taking advantage of 
Phosflow, we could detect the phosphorylation of SLP-76 in stimulated NK and T cells in the 
same sample thereby directly comparing the effects of inhibitors. B cells had to be stimulated 
and analyzed in a separate sample given the preliminary results indicating unspecific 
stimulation of B cells by CD16 antibody as well as unspecific binding of the p-SLP-76 
antibody. However, the PBMCs for B cell stimulation were prepared next to the NK/T cell 
stimulation using the same cell and inhibitor concentrations. 
Treatment with an inhibitor for SYK kinase but not ZAP70, SYKIV, decreased p-SLP-65 
positive B cells while hardly affecting the percentage of p-SLP-76 positive NK or B cells 
compared to the DMSO-treated stimulated control. Treatment with Src family kinase 
inhibitors PP1 and PP2 completely abolished the phosphorylation of SLP-76 in T cells at both 
10 μM and 5 μM. However, the percentage of p-SLP-76 positive NK cells was reduced but 
not completely inhibited. At the lower 5 μM concentration, NK cell phosphorylation of SLP-
76 upon stimulation was partly restored while still completely inhibited in T cells. B cells 
seemed even less affected by inhibition of Src family kinases than NK cells. For B cells, the 
data is only representative of only one donor thus excluding these results from statistical 
analysis and making further validation necessary.  
-0,2	0	
0,2	0,4	
0,6	0,8	
1	1,2	
1,4	1,6	
DMSO	control	 DMSO	stim	SYK	IV	2,5	μM	 PP1	10	μM	PP2	10	μM	 PP1	5	μM	 PP2	5	μM	Per
ce
nt
ag
e	
of
	p
os
it
iv
e	
ce
lls
	fo
r	
p-
SL
P-
76
	(Y
12
8)
	n
or
m
al
iz
ed
	to
	D
M
SO
	
st
im
ul
et
	s
am
pl
e	 NK	cells	T	cells	B	cells	
	 42	
4.5 Supplementary Results 
 
Figure 22. Supplementary results 1: Expression of NKp80 and CD45. Untransfected stained control in red, examples 
for co-transfected S2 cells stained for NKp80 or CD45 in blue.  
The expression of NKp80 and CD45 could not be verified by WB. Therefore, we analyzed 
NKp80 and CD45 expression by FACS. Shown are representative FACS results for 
expression of NKp80 and CD45 in co-transfected S2 cells.  
These results confirmed the expression and membrane localization of NKp80 and CD45 in S2 
cells.  
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Figure 23. Gating strategy for Phosflow. Lymphocytes were identified by FSC/SSC according to size and granularity. T 
cells were CD3+CD56-, NK cells were CD3-CD56+ and B cells CD3-CD19+. Here, B cells were stained after 
permeabilization leading to unspecific binding of CD19 in CD3+ cells.  
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5 Discussion 
The S2 system 
 
The S2 system as a tool for synthetic biology 
As demonstrated in the first experiment (Fig. 3), S2 cells can be transiently co-transfected 
with up to 10 different plasmids at once as shown by others [129]. Here we sorted the cells by 
co-expression of GFP and could therefore show directly that GFP positive cells express the 
other transfected proteins as well. Co-transfection of more than 3 proteins in S2 cells has only 
been verified indirectly by co-expression of SHP-1 or for only 2 proteins by flow cytometry 
[129]. We could directly demonstrate for the first time that S2 cells can be efficiently and 
transiently co-transfected with up to 10 different plasmids in one sample. This was further 
confirmed by FACS analysis of transfected receptors 2B4 and CRACC in the same 
experiment as most cells were double-positive for both. Integration of heterologously 
expressed adapters like CD3ζ into the cell membrane was thereby confirmed as well as 
reported by others before. Similar to human immune cells [138], CD16 did not incorporate 
into the membrane in S2 cells without the co-expression of CD3ζ or FcεR1γ. Taken together, 
these experiments showed that the S2 system could be used to rebuild and manipulate human 
signaling pathways by co-expression of heterologously expressed proteins. The evolutionary 
distance between insect cells and human cells should prevent interactions of intrinsic 
Drosophila proteins with the heterologously expressed mammalian proteins. However, it 
should be noted that despite their evolutionary distance to humans, S2 cells express many 
signaling components similar to human cells including homologues of ITAM receptors [149, 
150] and Vav1 [151]. Despite our best efforts to control for the activity of Drosophila 
proteins by treatment with inhibitors or H2O2/pervanadate, we cannot exclude that the 
possibility that Drosophila adapter proteins, phosphatases or kinases take part in our 
reconstructed pathways. Differences in post-translational modifications between human and 
insect cells might also affect interactions [152].  
 
SFK are constitutively active when expressed in S2 cells 
Furthermore, the S2 system proved to be of limited use when investigating pathways 
involving SFK. As demonstrated by others before and confirmed by our results, SFK are 
constitutively active when expressed in S2 cells. As this constitutive activation of Src family 
kinases could be a consequence of elevated H2O2 levels in S2 cells as suggested by others, we 
pretreated the S2 cells with the inhibitor DPI before harvesting to reduce H2O2 production. 
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Indeed, we observed less autophosphorylation as well as phosphorylation of co-expressed 
Fyn-targets 2B4 and Vav1 (Fig. 4, 5). However, cross-linking of 2B4 or CD16 did not lead to 
an increase in 2B4 or CD3ζ phosphorylation even when pretreated with DPI, respectively. 
While we could reduce autoactivation of Fyn by treatment with an inhibitor reducing H2O2 
levels, this might also interfere with the activation by cross-linking. 
As we could be missing essential signaling components to induce significant phosphorylation 
of 2B4 or Vav1 upon receptor cross-linking, we co-expressed more suspected components. 
We tried to recreate a 2B4 or CD16 minimal signaling pathway by co-expressing suspected 
components. For 2B4, we co-expressed the adapter protein SAP, that has been described as 
critical for activating signaling by 2B4 (Fig. 6). Co-expression of SAP did not influence the 
observed phosphorylation of 2B4. Additionally, we tried co-expression of other downstream 
molecules like EAT2, 3BP2, SLP-76, Vav1 and LAT. Co-expression of these proteins 
together with 2B4 and Fyn did not affect the constitutive phosphorylation of 2B4. Vav1 was 
phosphorylated every time when Fyn was co-expressed, independently of the co-expression of 
other proteins. The same could be observed for 2B4 phosphorylation (data not shown). 
Similar attempts involving CD16 were unsuccessful as well (data not shown). Thus, it was not 
possible to recreate an inducible minimal signaling pathway involving SFK. 
Additionally, we wanted to make this pathway inducible by cross-linking or engagement by 
its natural ligands. This would provide an additional level of validation for a potential 
minimal signaling pathway. Experiments co-expressing the 2B4 receptor with several 
combinations of downstream signaling molecules co-expressed in S2 cells did not result in 
enhanced phosphorylation when cross-linked by specific 2B4 antibodies or co-expression of 
the 2B4 ligand CD48 (data not shown).  
  
The phosphatase SHP-1 is active and specific when expressed in S2 cells 
Phosphatases play a key role in NK cell signaling, not only interfering with signaling by 
activating receptors but also to attenuate signaling after activation. We tried co-expressing the 
phosphatase SHP-1 with 2B4, Fyn and Vav1 and observed reduced phosphorylation of Vav1 
when SHP-1 was co-expressed (Fig. 7). This indicated that SHP-1 can directly 
dephosphorylate Vav1 as reported by others [123, 153]. Like Src family kinases, SHP-1 
seemed to be constitutively active when expressed in S2 cells. Co-expression of the inhibitory 
KIR2DL1 receptor containing ITIM motifs in its cytoplasmatic tail did not further enhance 
SHP-1 activity (data not shown). In contrast to an earlier study where SHP-1 co-expression in 
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S2 cells did reduce SYK-mediated SLP-65 phosphorylation [129], we did not observe a 
reduction in SYK-mediated SLP-76 phosphorylation.  
To summarize, these results demonstrate that SHP-1 is active when co-expressed in S2 cells 
and can counteract Fyn-mediated Vav1 phosphorylation. Thus, SHP-1 demonstrated substrate 
specificity when expressed in S2 cells as it did not dephosphorylate 2B4 or CD3ζ. Therefore, 
the S2 system can be used to investigate potential targets of SHP-1. In contrast to our 
findings, SLP-76 has been reported as a substrate of SHP-1 in T cells and NK cells [154]. 
Additionally, SYK kinases are under control of inhibitory receptors in NK cells, likely 
mediated by SHP-1 [155, 156]. Moreover, SHP-1 was constitutively active like SFK when 
expressed in S2 cells. Nonetheless, SHP-1 co-expression did not inhibit SYK activation or 
dephosphorylated SLP-76 in our experiments. As we could not enhance SHP-1 activity by co-
expression of an ITIM motif (data not shown), it was impossible to recreate an inhibitory 
pathway in S2 cells.  
 
Limitations of the S2 system 
Taken together, our findings revealed serious limitations in the usefulness of S2 cells to 
recreate a heterologously expressed signaling pathway. Given the constitutive activation of 
key signaling proteins like SFK, it was not possible to reconstruct a functional minimal 
signaling pathway relying solely on SFK for activation. Any given pathway would need to be 
controlled by selective expression of its components to control for autoactivation. As we 
established a plasmid-database of well over 50 signaling components relevant for NK cell 
signaling, it was mathematically impossible to test all combinations. Taking educated guesses, 
we tested many combinations of NK cell signaling components co-expressed in S2 cells to 
recreate a functional minimal signaling pathway, but many combinations remained untested 
and could be used in future experiments. Given the limitations of the S2 system, results have 
to be carefully controlled. Furthermore, we could not induce or enhance activation via 
external stimuli.  
However, we were able to identify a minimal signaling pathway using SYK kinases for 
activation, similar to studies before [129]. Our findings were carefully controlled for their 
dependency on the presence of an activating ITAM motif by selective co-expression and 
inhibitor experiments. 
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Predictions from the S2 system 
 
 
Figure 24. Proposed signaling pathways. (1) & (3) Canonical SYK/ZAP70 ITAM pathway. Fyn phosphorylates ITAM 
motifs and activates SYK/ZAP70. Activated SYK/ZAP70 phosphorylates SLP-76. (2) & (4) Non-canonical SYK-based 
ITAM pathway. SYK phosphorylates the ITAM motifs and is activated. Subsequently, SLP-76 is phosphorylated. 
ZAP70 alone cannot activate itself or phosphorylate ITAMs in this model. 
We could identify a minimal signaling pathway involving SYK kinases and their activation 
by ITAMs. Taken together, we were able to indentify three pathways dependent on ITAM co-
expression resulting in SLP-76 phosphorylation while we could exclude one possibility (Fig. 
25). Additionally to the well described canonical ITAM-SFK-SYK/ZAP70-SLP-76 pathway, 
we could identify a non-canonical pathway for SYK, but not ZAP70. In this pathway, SYK 
kinase is activated by a positive feedback loop that can amplify the signal without the need for 
SFK. Further experiments revealed that only SYK, but not ZAP70 can take part in this non-
canonical pathway. Additionally, we could confirm the canonical activation of SYK and 
ZAP70 by SFK in S2 cells. In this setting, SFK could be negatively regulated by co-
expression of Csk or positively regulated by co-expression of CD45. As SFK activate SYK 
and ZAP70 in the canonical pathway, SLP-76 phosphorylation could be indirectly regulated 
by their co-expression in this setting. In summary, our results predict the existence of 
canonical ITAM pathways relying on SFK for SYK and ZAP70 activation. Furthermore, we 
could construct a non-canonical pathway for SYK with NK cell specific signaling molecules. 
The observed pathways will now be discussed in detail. 
 
ITAM – SYK – SLP-76 
In our synthetic biology approach we found SLP-76 phosphorylation upon co-expression of 
an ITAM-containing adapter, SYK and SLP-76 in S2 cells (Fig. 8). Similar to previous 
studies [129], the initiation of this signaling pathway did not require engagement of a surface 
receptor and was likely induced by the overexpression of the ITAM-containing signaling 
chain in the S2 cells. We co-expressed and cross-linked CD16 together with CD3ζ, SYK and 
SLP-76 but observed no increase in SLP-76 phosphorylation upon cross-linking (data not 
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shown). While we only saw SLP-76 phosphorylation upon co-expression of ITAM-containing 
receptors in the S2-cells (Fig. 8), this does not exclude the phosphorylation of SLP-76 upon 
triggering of non-ITAM activating receptors as other adapters and kinases might build a 
different signaling pathway. In previous studies SLP-76 phosphorylation was partially 
induced by cross-linking of non-ITAM receptors such as NKG2D, 2B4 and DNAM-1 ([80] 
and Fig. 4A). This indicates that these pathways might function independently of SYK kinase. 
Indeed, NKG2D-DAP10 seems to rely on Src-family kinases [157] and triggers human NK 
cell cytotoxicity via a SYK-independent pathway [158, 159]. The same pathway has been 
described in T cells as well [160]. In contrast, triggering of ITAM-based receptors such as 
CD16 in NK cells induces the phosphorylation and activation of SYK and ZAP70 [161, 162] 
and these kinases are essential for the function of the receptors [163].  
Co-expression of DAP12 together with SYK and SLP-76 induced the strongest activation of 
SYK and subsequent phosphorylation of its target SLP-76. However, we did not quantify this 
finding. In chimeric antigen receptor (CAR) construction studies, DAP12 was shown to 
induce higher cytotoxicity than CD3ζ in this setting [164]. A possible explanation for this 
finding could be the ability of DAP12 ITAMS to activate SYK better than CD3ζ ITAMs as 
observed in the present study.  
 
A non-canonical pathway 
In our S2-cell system SYK-mediated SLP-76 phosphorylation did not require the activity of 
Src-family kinases. This differs from the canonical ITAM-based signaling pathway, where 
Src-family kinases are required for ITAM phosphorylation thereby providing a binding site 
for SYK activation. There have been previous reports for non-canonical ITAM signaling. In 
platelets, phosphorylation of SLP-76 was shown to be essential for ITAM receptor signaling 
[165] and SYK kinase was shown to be more important than Src-kinases for this signaling 
pathway [166]. Additionally, a similar minimal signaling pathway involving just SYK and an 
ITAM receptor has previously been shown to result in phosphorylation of SLP-65, a SLP-76 
related molecule in B cells [129].  
 
Structural requirement for SH2 domains of SYK and ITAM domains of CD3Ζeta 
Our mutagenesis data show that the minimal signaling pathway in S2-cells still relied on the 
presence of tyrosines in the ITAM receptor and on a functional SH2 domain in SYK (Fig. 10). 
This indicates that this non-canonical signaling pathway is still dependent on the canonical 
interaction of the SYK SH2 domains with the (phosphorylated) tyrosines of the ITAM despite 
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being independent of Src-family kinases. Therefore, SYK may be sufficient for ITAM-
phosphorylation under certain conditions. In contrast to earlier studies in B cell activation, we 
found that both the C terminal and the N terminal SH2 domain of SYK are critical for 
activation by ITAMs, whereas others identified the C terminal SH2 domain of SYK as the 
dominant regulatory site [130]. 
 
Kinase specificity 
In line with a previous study [129] we detected CD3ζ phosphorylation in the presence of SYK 
and lower phosphorylation in the presence of ZAP70 (Fig. 9), supporting this hypothesis. 
There have been several studies demonstrating that SYK may be more important for the 
function of ITAM-based receptors in NK cells than ZAP70 [155, 167, 168]. While testing the 
ability of other kinases involved in NK cell signaling to phosphorylate SLP-76 when co-
expressed with CD3ζ, in addition to SYK only ZAP70 demonstrated a weak ability to 
phosphorylate SLP-76 in S2 cells whereas Fyn, Lck and Csk did not phosphorylate SLP-76 in 
this setting. Of note, the Src kinase Fyn did phosphorylate CD3ζ significantly more than both 
SYK kinases SYK and ZAP70. These findings are in line with experiments by other groups 
that observed SYK mediated phosphorylation of SLP-76 in transfected Sf9 cells and to lesser 
extent by ZAP70, but not by the Src kinase Lck [169]. 
 
Enhanced by Vav1 
A known interaction partner of SLP-76 is Vav1. While trying to assemble a functional ITAM-
based pathway with signaling components downstream of SLP-76, we observed that SLP-76 
phosphorylation was significantly enhanced in the previously described CD3ζ, SYK, SLP-76 
minimal signaling pathway (Fig. 12). Vav1 is a well described interaction partner of 
phosphorylated SLP-76 [109, 170]. How Vav1 enhances SLP-76 phosphorylation in the S2 
system remained unclear. It could be that binding to Vav1 protects phosphorylated SLP-76 
against dephosphorylation by S2 phosphatases. Vav1 could also contribute to SYK activation 
or facilitate the interaction between SLP-76 and SYK. Interactions between Vav1 and SYK 
have been reported before [171]. Vav1 has also been reported to enhance SLP-76 
microclusters in T cells [172].  
 
SFK and SYK/ZAP70 
In the S2 system, we found that SYK can also be activated by co-expression of Fyn but this 
activation was further enhanced by co-expression of CD3ζ (Fig. 11). Co-expression of ZAP70 
	 50	
with SLP-76 alone or with CD3ζ did not result in significant SLP-76 phosphorylation. SLP-
76 was phosphorylated by ZAP70 when Fyn was co-expressed with SYK and this was further 
enhanced by co-expression of CD3ζ. Taken together, these results show that activation of 
ZAP70 seemed to be more dependent on Src family kinases than SYK, suggesting that 
ZAP70 is more involved in the canonical ITAM signaling pathway. This may be correlated 
with the fact that we saw weaker CD3ζ phosphorylation induced by ZAP70 compared to SYK 
so that additional phosphorylation by Fyn could enhance this signaling pathway (Fig. 9). The 
dominance of SYK over ZAP70 may therefore also be influenced by the fact that SYK can 
engage a non-canonical ITAM-based signaling pathway independently of Src-family kinases. 
SYK has been described as less dependent on SFKs for its catalytic activation, as it is able to 
trans-autophosphorylate and activate itself, although its activation is visibly enhanced by SFK  
[173]. In contrast, ZAP70 is highly dependent on SFK for its activation [174]. While SYK 
and ZAP70 are very similar in structure, each consisting of two SH2 and a kinase domain, 
ZAP70 has less than 50 percent homology with SYK in amino acid sequence [175]. Other 
studies have shown that ITAM binding by ZAP70 relieves an auto-inhibitory conformation of 
ZAP70 and that phosphorylation of specific tyrosine residues within the interdomain 
separating the C-terminal SH2 domain and the kinase domain (interdomain B) by SFK are 
important for regulating the activity of ZAP-70 [106, 176]. 
To further test this difference in regulation by Src family kinases, we treated the S2 cells with 
inhibitors specific for SYK but not ZAP70 or Src family kinases. Indeed, treatment with SYK 
kinase inhibitors SYKII and SYKIV decreased SLP-76 phosphorylation when expressed in 
the CD3ζ, Fyn, SYK, SLP-76 pathway whereas Src family kinases inhibitors PP1 and PP2 did 
not. In contrast, treatment with Src family kinase inhibitors PP1 and PP2 decreased SLP-76 
phosphorylation when expressed in the CD3ζ, Fyn, ZAP70, SLP-76 pathway. In a similar 
approach, COS cells were transiently co-transfected with different combinations of  chimeric 
CD8 receptor, SYK or ZAP70 and Lyn [177]. Comparable to the observations in this study, 
SYK was activated when co-expressed with an ITAM motif and able to phosphorylate the 
ITAM, but ZAP70 relied an activation by the Src kinase Lyn. SYK could also be activated by 
co-expression with Lyn alone.  
Given that SYK can also be activated by Fyn in the S2 system, this could explain why we 
could not detect any SLP-76 phosphorylation upon SFK-inhibition in NK cells by Western 
Blot as the canonical pathway seems to induce stronger phosphorylation of SLP-76 than the 
non-canonical SFK-independent pathway.  
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Findings apply to other cell types as well 
	
Figure	 25 Major ITAM-associated receptors and their canonical downstream signaling. The T cell receptor (TCR), 
which uses the CD3–ζ-chain complex for signalling; the B-cell receptor (BCR), which interacts with the signal-transducing 
subunits Igα (also known as CD79a) and Igβ (also known as CD79b); the low-affinity Fc receptor for IgG (FcgammaRIII; 
also known as CD16), expressed by natural killer (NK) cells and associates with dimers of either the ζ-chain or the 
structurally closely related gamma-chain (the IgE Fc receptor gamma-subunit). Canonically, the respective ITAMs are 
phosphorylated by SFK, which is followed by recruitment and activation of SYK family kinases to the phosphorylated 
ITAMs. T cells express the SYK family kinase ZAP70, whereas B cells express the SYK family kinase SYK. NK cells 
express both SYK and ZAP70. Edited and with permission from [178]. (SFK = Src family kinases) 
Our recreated signaling pathways did not rely on the expression of a specific receptor for their 
activation. Therefore, our findings should apply to all cell types that express these signaling 
molecules as well. For example, T cells express the CD3ζ chain as part of the TCR as well as 
ZAP70 and SLP-76 (Fig. 26).  
 
What does this mean for NK cells? 
Stimulating primary NK cells via activating receptors associated with ITAM-motifs resulted 
in SLP-76 phosphorylation in primary (Fig. 14) and activated (Fig. 15, 16, 17) NK cells as 
predicted by the minimal signaling pathway reconstructed in S2 cells. SLP-76 
phosphorylation after CD16 stimulation has been reported before [80], but to our best 
knowledge this is the first report of SLP-76 phosphorylation after cross-linking of NCRs. 
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SLP-76 phosphorylation could be effectively inhibited by the specific SYK inhibitors SYKII 
and SYKIV, demonstrating that SYK plays a critical role in SLP-76 phosphorylation in NK 
cells (Fig. 14, 17, 18). Moreover, SFK inhibitors PP1 and PP2 also inhibited SLP-76 
phosphorylation as observed by Western Blot (Fig. 14, 15). This is in line with previous 
findings that observed inhibition of SLP-76 phosphorylation in primary NK cells after cross-
linking of CD16 by PP1 and SYKIV as well [80]. These results would indicate that the 
canonical pathway relying on SFK kinases for activation of SYK is functional in NK cells. 
However, results obtained by FACS analysis revealed differential requirements for SFK 
comparing SYK/ZAP70 expressing NK cells and ZAP70 expressing T cells that will be 
discussed later. Given the greater sensitivity of flow cytometric analysis compared to Western 
Blot, these results showed that SLP-76 phosphorylation in NK cells is less reliant on SFK 
than in T cells. This could be attributed to the expression of SYK in NK cells thus validating 
the non-canonical ITAM-SYK-SLP-76 pathway observed in S2 cells (Fig. 8). 
 
How could this affect NK cell receptor synergy? 
It is also interesting to speculate what these results might mean for synergistic signaling by 
activating NK cell receptors as described before. We observed phosphorylation of both 
tyrosines Y113 and Y128 after cross-linking of ITAM-associated receptors CD16, NKp30 
and NKp46 in primary human NK cells (Fig. 14). To our best knowledge, this is the first time 
that SLP-76 phosphorylation was investigated after cross-linking of NKp30 and NKp46 in 
primary human NK cells. Both NCRs are not able to trigger NK cell effector functions alone 
on primary rested cells. Resting and IL-2-activated NK cells differ in their requirement for co-
activation [179] and it was suggested that synergistic SLP-76 phosphorylation is one reason 
why co-engagement of different activating receptors can stimulate resting NK cells [80]. This 
could also explain why in cytokine stimulated NK cells engagement of a single activating 
receptor results in phosphorylation of both tyrosines in SLP-76, resulting in sufficient NK cell 
activation. This indicates that SLP-76 cannot be the only intersection point of activating 
signals and NCR signaling therefore probably converges by another mechanism or molecule. 
Additionally, we observed phosphorylation of tyrosine Y113 and Y128 in activated NK cells 
when triggered via the 2B4 receptor. Only tyrosine 113 is phosphorylated when rested cells 
are triggered via 2B4 [80]. However, in activated NK cells engagement of 2B4 alone can 
trigger NK cell effector functions. Thus, this switch in SLP-76 phosphorylation of 2B4 
between primary rested and activated NK cells could provide a molecular basis for the 
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different requirements of synergistic signals. Respective pathways in primary and activated 
NK cells leading to SLP-76 phosphorylation by 2B4 and other non-ITAM receptors remain to 
be investigated. Cytokine stimulated NK cells can also show memory-like responses [17]. 
Epigenetic regulation was shown to be one reason for the enhanced function of memory-like 
NK cells [53]. However, a cytokine-induced switch in ITAM-based signaling from a 
canonical to a Src-independent, minimal SYK-dependent pathway may additionally modify 
the reactivity of these cells 
Cross-linking of NKp80 in activated NK cells did not result in detectable SLP-76 
phosphorylation. NKp80 signals through an atypical ITAM motif termed “hemiITAM” in its 
cytoplasmatic tail that has been reported to have impaired capability to recruit SYK. This 
could provide an explanation for the observation that NKp80 does not activate SYK in the S2 
system (Fig. 8) or phosphorylates SLP-76 upon cross-linking in activated NK cells. However, 
we and others observed SLP-76 phosphorylation induced by cross-linking of 2B4, that signals 
through ITSM motifs that do not recruit SYK either.  
 
Comparing NK, T and B cell signaling in primary cells 
As knockdown by siRNA in primary NK cells is hard to achieve, we compared the sensitivity 
of NK cells to SYK and SFK inhibitors with other immune cells only expressing SYK or 
ZAP70 by flow cytometry. A key advantage of this approach is the simultaneous stimulation 
and analysis of NK cells and T cells in the same sample. This enhances comparability as both 
cell types were stimulated in the presence of the exact same inhibitor concentrations and 
antibodies for flow-cytometric analysis. Furthermore, PBMCs are more representative of the 
in vivo situation as possible interactions with other mononuclear blood cells are still possible. 
B cells could not be analyzed in the same sample because of unspecific binding of the p-SLP-
76 antibody.  
In contrast to our findings by Western blot, flow cytometric analysis by intracellular staining 
did reveal differences in SLP-76 phosphorylation of primary NK cells after CD16 stimulation 
and inhibitor treatment (Fig, 21, 22). As flow cytometry can be conducted with 10-15 times 
fewer cells than Western Blotting, it could be that we did not load enough cells on our gels to 
see low level differences in SLP-76 phosphorylation after inhibitor treatment. Another 
possible explanation for this difference could be the lower threshold of antibodies binding to a 
given antigen for detection by flow cytometry. Therefore, we might detect lower levels of 
phosphorylation by flow cytometry than by Western Blot. In an earlier study, PP1 inhibited 
SLP-76 phosphorylation by CD16 cross-linking in primary NK cells significantly more than 
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SYKIV [80]. This difference was observed by Western Blot. However, we detected 
differences by flow cytometry for NK cell inhibition as well as between NK cells and T cells 
(and one B cell donor).  
The same concentration of SYKIV that seemed to block SLP-76 phosphorylation in isolated 
primary or expanded activated NK cells after CD16 cross-linking did not block SLP-76 
phosphorylation in NK cells when cross-linked via CD16 in PBMCs when analyzed by flow 
cytometry. This could be attributed to a lower detection threshold of phosphorylated SLP-76 
by flow-cytometry and would likely be mediated by the ITAM/SFK/ZAP70 pathway. In line 
with this theory, B cells are more and T cells less affected by the same SYKIV concentration 
upon stimulation, although both not statistically significant. In line with these results, a 
previous study compared the effects of SYKIV treatment on B cell and T cell calcium flux 
upon activation and found that this inhibitor only reduced calcium flux in B cells [140]. A 
potential other explanation could be unspecific binding of the p-SLP-76 antibody to other 
unaffected phosphorylated proteins which we observed regularly by Western Blot. It could 
also be the case that NK cells are less resistant to the SYKIV inhibitor when isolated than as 
PBMCs.  
Moreover confirming the differential regulation by SFK of SYK and ZAP70, inhibition of 
SFK revealed significant differences in SLP-76 phosphorylation levels between NK cells and 
T cells.  
Given the possible pathways predicted by the S2 system, these differences in sensitivity to 
SYK and SFK inhibitors could be explained by expression of SYK and ZAP70. In the S2 
system, SYK phosphorylates SLP-76 by a SFK-independent pathway consisting of an ITAM, 
SYK and SLP-76. Additionally, SYK could be activated and subsequently phosphorylated 
SLP-76 by the canonical pathway involving SFK. ZAP70 could only phosphorylate SLP-76 
by the canonical ITAM-SFK-ZAP70-SLP-76 pathway. Therefore, our findings postulate three 
ITAM-based minimal signaling pathways that result in SLP-76 phosphorylation.  
NK cells express both SYK and ZAP70, thereby inhibition of SYK still leaves the ZAP70 
pathway to phosphorylate SLP-76. Inhibition of SFK by PP1 and PP2 abolishes the ZAP70 
pathway relying on activation by SFK, leaving only the SFK-independent SYK pathway to 
phosphorylate SLP-76. Thus, these findings seem to confirm the functionality of the non-
canonical SFK independent ITAM-SYK-SLP-76 pathway in primary NK cells. This is further 
validated by the observation that SLP-76 phosphorylation was completely abrogated in T cells 
stimulated in the same sample. However, this could also be explained by differences in 
resistance or uptake of the inhibitors.  
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While our Phosflow results for B cells are only representative of one donor, they seem to 
confirm that B cells are more resistant to inhibition of SFK than T cells or NK cells. In this 
single experiment with B cells, B cell sensitivity seemed highest to inhibition by SYKIV and 
least affected by inhibition of SFK compared to both T and NK cells. This would further 
confirm that ZAP70 expressing cells rely more on SFK than SYK expressing cells. In line 
with these findings, a recent study found that PP1 could block calcium flux in T cells but not 
in B cells upon receptor cross-linking [140].  
If BCR signaling in B cells can be induced by a Src-independent pathway only by SYK is still 
debated. Some studies suggest that both pathways are possible [129], others report that only 
the canonical pathway involving Src family kinases is functional in B cells [180-182]. A 
recent study described differences in dependency on Src family kinase for SYK activation 
when the BCR was stimulated by antibody or ligands [183]. While antibody-induced 
stimulation was only delayed but not abolished when Src kinase activity was inhibited by PP2 
or a constitutively active LAT-Csk construct, ligand-induced BCR stimulation was 
completely abrogated when Src family kinases were inhibited [183]. Therefore, differential 
regulation of SYK by SFK could calibrate the threshold for BCR receptor activation. Further 
supporting this proposed mechanism to fine-tune the BCR response, ligation by monovalent 
or multivalent ligands seems to be differentially regulated by an interplay of SYK and SFK in 
B cells as well [184]. It is interesting to speculate if a similar mechanism applies to NK cells. 
As NK cells additionally express the SYK kinase ZAP70, functional differences could be 
regulated by expression of SYK and ZAP70. Both SYK and ZAP70 function as adapter 
proteins as well [166, 185], therefore differences in interaction partners could enhance 
respective specific signaling pathways initiated by SYK or ZAP70. Loss of SYK expression 
has been associated with memory-like NK cells after HCMV infection [186]. Lck, Fyn and 
Zap70 deficient murine NK cells still have natural cytotoxicity mediated by SYK [155]. 
In another study, the absence of CD45 affected ZAP70 but not SYK signaling in murine NK 
cells [167]. In murine studies, SYK was indispensable for DAP12 signaling but ZAP70 not 
necessary [168]. Many other cell types have been reported to be affected by differential 
expression of SYK and ZAP70 that can affect cell functions. In osteoclasts, SYK is critical 
for cytoskeleton organization. Osteoclasts deficient for SYK could be rescued by expression 
of SYK, but not ZAP70 as evidenced by cytoskeleton organization and SLP-76 
phosphorylation. Expression of ZAP70 even inhibited SYK-mediated phosphorylation of 
SYK, Vav3 and SLP-76 [187]. In platelets, the SLP-76 tyrosines are important for ITAM-
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signaling [165] and SYK seems to be more important than Src for activation and SLP-76 
phosphorylation [166]. 
 
Control by Csk, CD45 
The kinase Csk and the phosphatase CD45 reciprocally regulate phosphorylation of the 
inhibitory tyrosine of the Src family kinases Lck and Fyn [105, 188, 189]. CD45 can 
desphosphorylate the negative regulatory tyrosine of Src family kinases [105] while it is 
phosphorylated by Csk. The adapter protein PAG is critical for membrane recruitment of Csk 
to receptor complexes [141]. In a similar approach utilizing HEK-cells, co-expression of 
CD45, Csk and PAG with CD3ζ, ZAP70 and Lck controlled CD3ζ and activating Lck/ZAP70 
phosphorylation [141]. Therefore, we co-expressed CD3ζ, Fyn, SYK or ZAP70, SLP-76 with 
combinations of CD45, Csk and PAG. We found that co-expression of Csk inhibited SLP-76 
phosphorylation mediated by both SYK and ZAP70 in S2 cells, presumably by inhibiting 
SFK (Fig. 13). As SYK was co-expressed with Fyn in this experiment, inhibition of Fyn by 
Csk was sufficient to block SYK activation. While the non-canonical pathway should still be 
functional, Fyn-mediated activation of SYK could induce a stronger phosphorylation. Co-
expression of PAG, reported by others as necessary for membrane recruitment of Csk [141], 
did not further reduce SLP-76 phosphorylation levels. However, expression of PAG could not 
be verified as there was no commercial antibody available. Co-expression of CD45 
counteracted Csk and restored SLP-76 phosphorylation and presumably enhanced it when co-
expressed in the ZAP70 pathway. These results showed that SFK can be regulated 
reciprocally by Csk and CD45, directly affecting SFK-mediated activation of SYK and 
ZAP70 when co-expressed with ITAMs. Our results could provide the molecular basis for 
previous obervations by others as discussed. The non-canonical ITAM-SYK-SLP-76 pathway 
without co-expression of Fyn was not affected by CD45 or Csk co-expression in S2 cells 
(data not shown). 
Studies in T-cell lines and in the CD45-deficient mouse underline the importance of CD45 for 
SFK activity. CD45-deficient T-cell lines contain Lck and Fyn molecules that are 
hyperphosphorylated at their C-terminal negative regulatory tyrosines and demonstrate a 
significant reduction in TCR-stimulated phosphotyrosine induction  [190, 191]. CD45-
deficient mice have few peripheral T cells since TCR signaling during thymic development is 
greatly impaired [192, 193]. However, B cell development was not impaired in these studies, 
further supporting our model if differential regulation of SYK and ZAP70 expressing cell 
types.  
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In CD45 deficient murine NK cells, CD45 independent ITAM signaling is mediated by SYK, 
but not by ZAP70 [167]. A possible molecular basis for this report could be the non-canonical 
SYK-pathway described in this study. In the absence of CD45, SFK cannot be activated as the 
inhibitory tyrosine is not dephosphorylated, thus only the non-canonical SYK activation 
without SFK remains active. Signaling pathways in CD45-deficient NK cells are dysregulated 
and lead to differentially regulated cytotoxicity and cytokine production [194]. Expression of 
different CD45 isoforms [195] might also affect NK cell effector functions via regulation of 
SFK and subsequently SYK family kinases. 
 
Concluding remarks  
The initial findings regarding the ITAM-SYK-SLP-76 pathway are very similar to a study 
conducted in S2 cells as well but using more B cell specific ITAMs and SLP-65 [129]. 
Nevertheless, we could confirm some of these findings with NK cell specific signaling 
components while also revealing additional differences in the regulation of SYK and ZAP70 
by SFK. We could successfully reconstruct a functional non-canonical minimal signaling 
pathway in S2 cells. Additionally, we could demonstrate that activation of ZAP70 relies on 
SFK as in the canonical ITAM pathway. SYK could also be activated by the canonical 
pathway. Furthermore, activation of ZAP70 could be reciprocally regulated via Fyn by Csk 
and CD45. We could confirm the existence of all three postulated pathways in primary 
immune cells taking advantage of the differential expression of SYK and ZAP70 in NK, B 
and T cells. SYK expressing NK and B cells were more resistant to inhibition by SFK 
inhibitors than ZAP70-only expressing T cells, providing evidence for the non-canonical 
ITAM-SYK-SLP-76 pathway. While we could not validate the regulation of the canonical 
pathway by Csk and CD45 in primary immune cells, our findings could provide the molecular 
basis for observations by others [167] in the absence of CD45. Taken together, our data 
support the existence of a non-canonical ITAM-SYK-SLP-76/SLP-65 pathway while also 
confirming the canonical ITAM-SFK-SYK/ZAP70-SLP-76/SLP-65 pathway and its 
reciprocal regulation by Csk and CD45. However, given the possibility that primary immune 
cells were stimulated by cross-linking with specific antibodies, we cannot exclude that the 
non-canonical pathway is an artifact induced by the artificial and strong stimulus. 
 
 
 
 
  
	 58	
6 Outlook 
Given the observed limitations of the S2 system for signaling studies, the obtained results 
should be taken with care. While we could elucidate differences in regulation of SYK and 
ZAP70 in S2 cells and validate these results by treatment of primary immune cells with 
inhibitors, further validation by other methods like selective siRNA knockdown of either 
SYK or ZAP70 should be conducted. These experiments could provide further insight into 
how SYK and ZAP70 affect NK cell effector functions, which have not been investigated in 
this study.  
Additionally, the results obtained with primary cells were induced by cross-linking. As cross-
linking by antibodies is an artificially strong stimulus, this could induce signaling pathways 
that do not exist in vivo. Our observed non-canonical ITAM-SYK-SLP-76 pathway could be 
such an artifact. Therefore, further studies with natural ligands have to be performed to test 
the validity of this pathway in vivo. 
 
 
 
 
 
 
 
Richard Feynman: 
“We are at the very beginning of time for the human race. It is not unreasonable that we 
grapple with problems. But there are tens of thousands of years in the future. Our 
responsibility is to do what we can, learn what we can, improve the solutions, and pass them 
on.” [196]  
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7 Methods 
7.1 Cell culture 
7.1.1 NK cell isolation and culture 
Human blood samples from healthy donors were drawn for research purposes at IfADo. All 
donors gave written consent. All media and supplements were from Thermo Fisher Scientific, 
unless stated otherwise. Peripheral blood mononuclear cells (PBMC) were isolated from 
blood by Ficoll density gradient centrifugation (PAN-Biotech, Germany). Human NK cells 
were purified from PBMCs using the Dynabeads Untouched Human NK Cell kit (Thermo 
Fisher Scientific) according to manufacturers instructions. For NK cell activation and 
expansion, purified NK cells were cultured in 96-well round-bottom plates (Nunc) with 
irradiated K562-mbIL15-41BBL (kind gift from Dario Campana) in IMDM Glutamax 
supplemented with 10% FCS and 1% Penicillin / Streptomycin, IL-2 (100 U/ml, NIH 
Cytokine Repository) and IL-15 (5 ng/ml, Pan Biotech). IL-21 (100 ng/ml, Miltenyi Biotec) 
was added at the first day. NK cells were between 90% and 99% CD3−,  CD56+ and NKp46+ 
as assessed by flow cytometry. 
7.1.2 Schneider cell culture and transient transfection 
Schneider S2-cells (Invitrogen) were grown in Schneider's Drosophila medium (Serva) 
supplemented with 10% FCS at 26°C without CO2. Cells were passaged every 2 to 3 days to 
maintain exponential growth. S2 cells were transfected using Lipofectamine 2000 (Life 
Technologies, Inc.). For transfections, the S2 cells were seeded in a 6-well plate (Sarstedt) at 
1 × 106 per well in 3 ml medium and incubated over night. Supercoiled plasmids (0.3 µg of 
each plasmid were adjusted with pRmHa-3 to equal DNA concentrations  per well) were 
complexed with lipid (6 µl Lipofectamine 2000 Reagent) in 0.5 ml OptiMEM Glutamax 
medium (Life Technologies, Inc.). The complex was incubated at room temperature for 30 
min and then added drop-wise to the cells. After 24-48 h CuSO4 (0.5 mM) was added to the 
culture for 36-48 h to induce the expression of proteins. For inhibitor experiments, SYKIV 
inhibitor (Calbiochem, 2.5 μM), PP1 (Biomol, 10 or 5 μM) or DMSO solvent control were 
added to the cells 1 h prior to harvesting. CuSO4-induced GFP+ cells were enriched by cell 
sorting (BD Jazz). Purity of GFP positive cells was greater than 80% after enrichment. 
Receptor expression was analyzed by FACS using the following antibodies: 2B4-APC (C1.7), 
CRACC-PE (162.1), NKp80-PE (5D12) all from Biolegend. All samples were measured on a 
LSR Fortessa and data were analyzed using the FlowJo software (TreeStar, Inc.).  To inhibit 
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H2O2 production, S2 cells were incubated for 1 hr with DPI (Diphenyleneiodonium chloride) 
solved in DMSO (final concentration: 16.7 µg/ml or 53 µM).  
 
7.2 Molecular biology and biochemisty 
7.2.1 SDS-PAGE and Western Blotting (Wet blot) 
Equal cell numbers of enriched GFP+ S2-cells or NK cells were lysed on ice in lysis buffer 
(0,5% Triton X, 2 mM EDTA, 10 mM NaF, 20 mM Tris-HCl, 150 mM NaCl, 10% (v/v) 
glycerol, pH 7,3) supplemented with proteinase and phosphatase inhibitor cocktails (Roche). 
Cell lysates were cleared by centrifugation and the supernatants mixed with reducing SDS 
sample buffer (5x concentrated buffer was added to the sample in a 1:5 ratio). The proteins 
were denatured by boiling the lysates for 5 min at 95°C. The proteins were separated by 
discontinuous SDS-PAGE [197]. The acrylamide concentration was chosen depending on the 
size of the proteins of interest. A higher percentage of acrylamide leads to a better separation 
of proteins of lower molecular weight, whereas lower percentages are optimal for the 
separation of proteins with higher molecular mass. Usually a acrylamide concentration of 
10% or 12% was used. 
A PVDF membrane (ImmobilonTM-FL, Millipore) was activated for 1 min in 100% MetOH. 
Whatman paper was also incubated for 1 min in the transfer buffer. A stack was built up with 
a sponge with three Whatman paper each on top and bottom, PVDF membrane and SDS gel 
in between. The transfer was performed in a transblot tank (BioRad) in transfer buffer. Since 
the PVDF membrane surface binds any protein, free binding sites were blocked by incubation 
of the membrane for 1 h at RT with 5% milk powder in PBS-T. Afterwards, the membrane 
was washed three times for 5 min with PBST and incubated for 1 h at RT or 4°C overnight 
with the indicated primary antibodies. After washing to remove unspecifically bound 
antibodies, bound primary antibody was detected by a horseradish peroxidase (HRP) labeled 
secondary antibody. HRP oxidizes its substrate luminol to an instable compound that emits 
light while decaying. The chemoluminescence was detected using a Fusion Fx7 (Filber). 
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Table 2: 10% SDS gels 
Stacking gel  Separating gel (10%)  
H2O 4.45 ml H20 3.4 ml 
Upper buffer 4X 1.9 ml Lower buffer 4X 2 ml 
Acrylamide 1.2 ml acrylamide 2.7 ml 
10% APS 75 µL 10% APS 50 µL 
TEMED 7.5 µL TEMED 7.5 µL 
 
 
Table 3: 12% SDS gels 
Stacking gel  Separating gel (12%)  
H2O 4.45 ml H20 2.8 ml 
Upper buffer 4X 1.9 ml Lower buffer 4X 2 ml 
Acrylamide 1.2 ml acrylamide 3.2 ml 
10% APS 75 µL 10% APS 75 µL 
TEMED 7.5 µL TEMED 7.5 µL 
 
Upper buffer: 0.5 M Tris, 0.4%SDS in dH2O, pH 6.8 
Lower buffer: 1.5 M Tris, 0.4% SDS in dH2O, pH 8.8 
 
NK cell stimulation 
For inhibitor experiments, NK cells were preincubated with the indicated inhibitors or solvent 
control for 30’ at 37°C and subsequent steps conducted in the presence of inhibitors. For 
antibody-mediated crosslinking, rested or activated NK cells were preincubated with the 
following antibodies at 10 µg/ml for 30 min on ice: NKp80 (5D12), NKp46 (9E2), CD16 
(3G8) from Biolegend. NKp30 (p30-15), NKp44 (p44-8) were produced in our lab. After 
washing with medium, NK cells were stimulated by crosslinking with goat anti-mouse F(ab′)2 
Ab (20 µg/ml, Dianova) at 37°C for 2 min, washed in ice-cold PBS, lysed and analyzed by 
Western Blotting as described above. 
 
7.2.2 Cloning 
For transient co-transfection experiments in Drosophila Schneider cells, the expression vector 
pRmHa-3 (Fig. 26) containing an inducible metallothionein promoter [137] was used. Some 
vectors were obtained from BIOSS. 
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The cDNAs of human NK cell signaling components were inserted into pRmHa-3 (Fig. 27) 
and verified by sequencing (GATC Biotech).  
 
 
Figure 26. Map of pRmHA-3 
 
List of plasmids cloned in our lab: 
Plasmid Insert Cloning sites Cloned by 
pD-DAP10 NM_014266   Mina 
pD-DAP12 NM_003332.3	 SalI/NotI Mina 
pD-NKp80 NM_016523	 SalI/NotI Mina 
pD-GFP     Simone 
pD-SAP NM_002351	(SAP)	 SalI/NotI Frank 
pD-EAT2 NM_053282	(EAT2)	 SalI/NotI Frank 
pD-LCK NM_005356	 SalI/NotI Mina 
pD-SLP76 NM_005565	 SalI/NotI Mina 
pD-VAV1 NM_005428.3	 SalI/NotI Mina 
pD-SHIP1 NM_001017915.2	 KpnI/BamHI	 Mina 
pD-CD16 NM_001127592.1	 EcoRI/NotI	 Mina 
pD-NKp30   SalI/NotI Frank 
pD-NK46   SalI/NotI Frank 
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pD-NKG2D     Christian 
pD-2B4 NM_016382.3	 SalI/NotI Mina 
pD-CRACC NM_021181	 SalI/NotI Mina 
pD-
KIR2DL1 NM_014218	 SalI/NotI	 Mina 
pD-FceR1G NM_004106	   Mina 
pD-LAT     Mina 
pD-GRB2 NM_002086.4	 SalI/NotI	 Mina 
pD-PAG1-
FLAG   EcoRI Mina 
pD-3BP2 NM_003023.4	 SalI/NotI	 Mina 
pD-CrkL NM_005207.3	 SalI/NotI	 Mina 
pD-ITK NM_005546.3	 SalI/NotI	 Mina 
pD-BTK NM_000061.2	 SalI/NotI	 Mina 
pD-CSK NM_004383	 SalI/NotI	 Mina 
pD-PLCG1 NM_002660	(silent	mutation	C->	A)	 SalI/NotI	 Mina 
pD-CD48 NM_001778.3	 EcoRI/SalI Mina 
pD-p85 NM_181523.2	 SalI/NotI	 Mina 
pD-p110 NM_005026.3	 SalI/BamHI Mina 
pD-
CD45RABC     Mina 
pD-
CD45RO     Mina 
 
 
7.2.3 Flow cytometric analysis (FACS) 
For flow cytometric analysis, S2 cells were washed with FACS buffer and resuspended in 
100µl FACS-buffer. After staining for 20’ on ice, cells were washed and analyzed by flow 
cytometry. The FACS analysis was performed using a BD LSR Fortessa flow cytometer (BD 
Biosciences). Cell sorting was performed on a BD Jazz (BD Biosciences). The data analysis 
was done with FlowJo v. 6.1.1 analysis software (Tree Star Inc.). 
 
Phosflow stimulation and staining 
For detection of phosphorylated intracellular proteins by FACS, BD Phosflow was applied 
according to the manufacturers instructions.  
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Freshly isolated PBMCs were preincubated on ice with primary antibodies against CD16 
(3G8), CD3-PerCP (UCHT1) and/or CD28 for 30’. After washing, the PBMCs were 
incubated with secondary goat anti mouse IgG. For BCR stimulation, cells were preincubated 
with IgM. Cells were incubated at all times in the presence of inhibitors at the indicated 
concentrations or DMSO vehicle control. To induce stimulation, the cells were incubated for 
2’ at 37°C and immediately fixed with BD Cytofix buffer for another 10’ at 37°C. 
Subsequently, the cells were washed and permeabilized by adding BD Phosflow Perm Buffer 
II for 30’ on ice. Cells were then washed twice and stained with the following antibodies: p-
SLP-76 Y128 AF647, p-SLP-65 AF647, CD56 BV421, CD19 AF700 (all from BD), CD3 
PerCP (Biolegend). Cells were washed and analyzed on a BD LSRFortessa.  
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8 Material 
 
8.1 Buffers	and	solutions	
Blocking buffer  
ECL solution 1 250 mM luminol (Sigma-Aldrich), 90 mM p-
coumaric acid (Sigma-Aldrich) in 0.1 M 
Tris-HCl pH 8.5 
ECL solution 2 0.1% H2O2  in 0.1 M Tris-HCl pH 8.5 
FACS buffer PBS + 2% FCS 
FACS washing buffer PBS + 2% FCS 
FCS Gibco 
Lysis buffer 0.5% Triton X, 2 mM EDTA, 10 mM NaF, 
20 mM Tris-HCl, 150 mM NaCl, 10% (v/v) 
glycerol, pH 7.3 
PBS Gibco 
Phosflow fixation buffer BD Phosflow Fixation buffer 
Phowflow permeabilization buffer BD Perm 2 
Primary antibody solution 5% BSA, 0,1% NaN3 in PBST 
SDS-PAGE running buffer MOPS buffer (Invitrogen) 
SDS-PAGE sample buffer 300 mM Tris, 46% glycerol, 10% SDS, β- 
mercaptoethanol, bromophenol blue in dH2O 
Secondary antibody solution PBST 
Transfer buffer  
WB washing buffer PBS + Tween 20 
 
 
8.2 General	equipment	
Autoclave Systec DX-150 
CASY cell counter Modell TT, Roche Diagnostics 
Cell culture 6 well plates Sarstedt 
Centrifuges Heraeus Fresco 21 (Thermo Scientific) 
Heraeus Megafuge 40R (Thermo Scientific) 
Falcon tubes Sarstedt 
Filtration systems, sterile Stericup, Milipore Corporation, Bedford, MA, 
USA 
Flow cytometers BD LSR Fortessa 
BD FACSJazz 
Incubators HERAcell 240i, Heraeus Instruments GmbH, 
Fellbach Germany 
pH-Meter PB-11 (Sartorius) 
Pipetboy Accu Jet Pro (Brand) 
Pipettes Gilson 
Power supply for SDS-PAGE/WB Power Pac (Biorad) 
SDS-PAGE and Tank-Blot equipment Biorad 
Sterile hood SAFE 2020; Thermo Scientific 
Thermomixer Thermomixer comfort (Eppendorf) 
Vortex IKA; Bioblock Scientific 
Western Blot detection Vilber Fusion Fx 7 
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Purified water  Milli Q Direct 8 (Millipore) 
8.3 Chemicals	
Dimethyl sulfoxide (DMSO) J.T. Baker / Sigma 
Acrylamid Roth 
Ammonium persulfate Roth 
Bovine serum Albumin (BSA) fraction V Roth 
Calciumchlorid-dihydrate (S2 supplement) Merck 
EDTA  
Ethanol Roth 
Methanol Roth 
Milk powder Saliter 
PageRuler™ Prestained Protein Ladder, 10 
to 180 kDa 
Thermo Fisher Scientific #26616 
 
Phosphatase inhibitor cocktail Roche 
Protease inhibitor cocktail Roche 
Sodiumhydrogencarbonate Grüssig 
ß-mercaptoethanol  
TEMED Sigma 
Tris Roth 
Tween 20 Roth 
 
 
8.4 Disposables	
Eppendorf tubes Sarstedt 
FACS tubes BD 
Gloves Latex gloves from Sempermed 
Pipettes 5/10/25/50 ml Sarstedt 
PVDF membrane Immobilon, Millipore 
Tissue culture flasks Sarstedt 
Watman paper Sigma 
 
 
8.5 Cell	culture	medium	and	supplements	
S2 medium SERVA 
Fetal calf serum (FCS) Gibco 
HEPES Gibco 
PBS Dulbecco’s PBS (Gibco) 
RPMI 1640 Gibco 
Penicillin-Streptomycin Gibco 
L-Glutamine Gibco 
Lipofectamine 2000/3000 Life Technologies 
IL-2 NIH Cytokine Repository 
IL-15 Pan Biotech 
Il-21 Milteny Biotec 
OptiMEM Life Technologies 
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8.5.1 Inhibitors	
SYKII Cayman Chemical Company 
SYKIV Cayman Chemical Company 
PP1 Cayman Chemical Company 
PP2 Cayman Chemical Company 
DPI  (Diphenyleneiodonium chloride) Sigma 
8.6 DNA	
The following plasmids were obtained from the BIOSS Centre for Biological Signalling 
Studies in Freiburg and verified in our lab by sequencing:  
pD-Syk, pD-Zap70, pD-Fyn, pD-SHP-1, pD-TCRZeta, pD-ZetaY1-4F, pD-ZetaY1-6F 
 
8.7 Antibodies	
8.7.1 Primary	antibodies	for	FACS	analysis	and	Phosflow	
For Phosflow: 
p-SLP-76 Y128 AF647, p-SLP-65 AF647, CD56 BV421, CD19 AF700 (all from BD), CD3 
PerCP (Biolegend).  
For expression analysis: 2B4-APC (C1.7), CRACC-PE (162.1), NKp80-PE (5D12), CD45-PE 
all from Biolegend. 
 
8.7.2 Primary	antibodies	for	Western	Blot	
Antibodies: pY113-SLP-76 (J80-373), pY128-SLP-76 (J141-668.36.58) (BD Biosciences); 
isotype control mouse IgG1 (MOPC-21) (Sigma); SLP-76 (#4958), ZAP70 (D1C10E) (Cell 
signaling); CD3-Ζ, Syk (SYK-01) (Biolegend); Fyn, DAP10, DAP12, FceRg, 2B4, SHP-1, 
GAPDH (GA1R) (Thermo Scientific); Csk (C14520 Transduction Laboratories).  
 
8.7.3 Secondary	antibodies	
Detection 
HRP Goat anti-mouse IgG (Biolegend #	405306) Goat Polyclonal Ig 
HRP Donkey anti-rabbit IgG (Biolegend #	406401) Donkey polyclonal Ig 
HRP Goat anti-rat IgG (Biolegend #	405405) Goat Polyclonal Ig 
 
Cross-linking 
Goat IgG anti-Mouse IgG (H+L)-unconjugated. (Dianova #115-005-003 Jackson 
ImmunoResearch) 
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8.8 Cells	
Primary rested PBMCs Isolated from blood donations in our lab 
Cultivated, expanded NK cells Cultivated from isolated NK cells as 
described 
Schneider (S2) cells Purchased from Invitrogen 
Feeder cells for NK cell culture Gift from Dario Campana 
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9 Abbreviations	
3BP2  SH3 domain-binding protein 2 (aka SH3BP2) 
Ab  Antibody 
ADCC  Antibody-dependent cell-mediated cytotoxicity 
BCR  B cell receptor 
CLP  common lymphocyte progenitor 
Csk  C-terminal Src kinase 
CTL  Cytotoxic lymphocytes 
DAP10 DNAX-activation protein 10 (aka HCST) 
DAP12 DNAX-activation protein 12 (aka TYROBP) 
DMSO Dimethyl Sulfoxide 
EAT2  EWS/FLI1-activated transcript 2 (aka SH2D1B) 
FACS  Fluorescence-activated cell sorting 
FCS/FBS Fetal bovine serum   
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GFP  Green fluorescent protein 
Grb2  Growth factor receptor-bound protein 2 
HRP  horseradish peroxidase 
FN-γ  Interferon gamma 
IgG  Immunoglobulin G 
IL  Interleukin 
ILC  Innate lymphoid cells 
IS  Immunological synapse 
ITAM  Immunotyrosine-based activation motif 
ITIM  Immunotyrosine-based inhibitory motif 
ITSM  immunoreceptor tyrosine-based switch motif 
IVIg  Intravenous	immunoglobulin 
kDa  Kilo-Dalton 
KIR  Killer-cell immunoglobulin-like receptors  
LAT  Linker for activation of T-cells family member 1 
Lck  Lymphocyte cell-specific protein-tyrosine kinase 
MHC  Major histocompatibility complex 
NCR  Natural cytotoxicity receptor 
NCR  Natural cytotoxicty receptors 
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NK cell  Natural killer cell 
PI3K  Phosphoinositide 3-kinase  
PLCy  Phospholipase Cy 
RT  Room temperature 
S2 cells Schneider cells  
SAP  SLAM-associated protein (aka SH2D1A) 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SFK  Src family kinases 
SH2  Src homology 2 
SH3  Src homology 3 
SHIP1  Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1 
SHP-1  Src homology region 2 domain-containing phosphatase-1 
SLAM  signaling lymphocytic activation molecule 
SLP-76 SH2 containing leukocyte protein of 76 kDa (also LCP2) 
SRR  SLAM-related receptors 
SYK  Spleen tyrosine kinase 
TCR  T cell receptor 
TNF-α  Tumor necrosis factor alpha 
uL  Mikroliter 
uM  Mikromolar 
WB  Western Blot 
ZAP70 70 kDa ζ-chain associated protein 
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